rfhg_70186.1

Basic information about the TSS

---

TSS ID: rfhg_70186.1 Species: human Chr: chr5		Start: 95717672 End: 95717681 Strand: +
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000504949.1:-39 AK023621:-39 GeneID: 22836 HGNC/MGI_ID: HGNC:18757 UniProt_ID: Nearer transcript ids and distances:

Gene_name: Rho related BTB domain containing 3 Gene_symbol: RHOBTB3 Gene_synonyms: KIAA0878 Gene_source: HGNC:18757

TATA-Box annotation

---

Distance to TSS:	-13660
Nearest PromoterID:	NM_014899
Entrez ID:	22836
Nearest Unigene:	Hs.445030
Nearest Refseq:	NM_014899
Nearest Ensembl:	ENSG00000164292
Gene Name:	Rho related BTB domain containing 3
Gene Alias:	-
Gene Type:	protein-coding
CpG%:	0.111111
GC%:	0.400000
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@RHOBTB3 p2@RHOBTB3 p3@RHOBTB3 p4@RHOBTB3 p5@RHOBTB3 p6@RHOBTB3 p7@RHOBTB3 p8@RHOBTB3 p10@RHOBTB3
Sample		p1@RHOBTB3	p2@RHOBTB3	p3@RHOBTB3	p4@RHOBTB3	p5@RHOBTB3	p6@RHOBTB3	p7@RHOBTB3	p8@RHOBTB3	p10@RHOBTB3
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	9.35	10.71	1.17	3.51	1.36	0.39	0.39	0.00	0.39
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	8.30	13.35	0.40	3.64	1.62	0.81	0.40	0.00	0.61
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	7.52	11.57	1.93	4.24	0.96	0.58	0.19	0.00	0.58
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	8.73	12.68	0.62	4.16	0.21	1.04	0.42	0.00	0.62
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	7.20	15.52	0.22	5.40	1.35	0.22	0.90	0.00	0.90
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	6.20	12.21	0.58	3.10	1.74	0.19	0.97	0.39	0.58
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	8.28	13.07	0.87	4.36	1.09	0.44	1.53	0.22	1.31
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	9.93	11.38	0.73	4.36	0.73	0.97	0.73	0.00	0.48
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	8.55	12.40	0.85	4.27	0.64	0.43	0.85	0.21	0.43
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	6.38	15.65	0.00	2.32	0.58	0.00	2.32	0.00	2.32
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	2.83	15.36	0.40	2.43	0.40	0.81	0.40	0.40	1.21
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	6.91	17.48	1.63	2.44	0.81	0.00	0.81	0.41	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	17.25	18.38	6.13	3.87	2.10	1.45	0.32	0.16	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	8.42	9.62	1.65	3.61	1.35	0.60	0.45	0.00	0.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	12.95	14.71	4.17	3.07	1.54	0.44	0.22	0.88	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	8.80	18.11	3.02	5.03	1.01	0.50	0.50	0.25	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	8.52	15.51	1.75	3.93	1.75	1.53	0.44	0.00	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	10.55	16.03	0.00	2.95	1.27	0.42	0.84	0.00	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	11.20	9.60	1.07	2.13	0.00	0.00	1.07	0.00	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	12.79	12.94	2.56	4.06	1.81	1.05	0.15	0.15	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	12.70	14.84	2.41	4.54	1.74	1.07	0.67	0.27	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	10.88	15.02	3.11	3.97	1.21	0.86	0.17	0.00	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	11.12	13.57	2.33	3.10	2.07	0.90	0.90	0.26	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	11.16	15.29	2.67	3.88	0.49	0.97	0.73	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	7.48	13.42	2.32	4.90	2.84	0.77	1.03	0.77	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	8.55	15.19	3.17	4.43	2.53	0.32	0.95	0.00	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	7.14	12.64	1.65	1.65	1.65	0.55	1.65	0.00	1.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	12.02	12.02	2.83	4.48	2.83	0.94	0.00	0.71	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	10.98	9.37	1.94	2.42	2.91	1.62	0.81	0.16	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	12.12	10.13	4.71	1.99	1.27	1.45	0.36	0.00	0.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	9.21	12.35	1.88	2.30	1.67	0.84	0.00	0.21	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	8.99	12.31	1.76	2.54	1.37	0.59	0.59	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	10.55	9.29	1.90	2.11	1.90	0.84	1.06	0.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	5.28	5.11	1.48	2.31	0.49	0.16	0.49	0.00	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	8.41	8.41	2.06	1.12	2.24	0.75	0.37	0.56	0.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	12.26	12.65	1.34	4.98	2.11	0.57	0.38	0.19	0.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	8.58	11.04	1.64	2.86	1.43	0.00	0.20	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	7.46	8.87	2.62	2.82	1.01	0.60	0.40	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	7.29	7.29	1.62	1.35	0.54	0.81	0.00	0.54	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	7.92	11.52	0.96	1.92	1.44	0.96	0.00	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	8.23	9.88	1.18	1.88	1.88	0.71	0.00	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	3.95	4.39	1.02	1.61	0.73	0.29	0.15	0.00	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	6.12	9.28	1.69	1.05	2.32	0.63	0.21	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	6.99	9.44	2.10	2.45	1.57	0.35	0.70	0.35	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	8.23	8.23	1.61	1.41	1.61	0.20	0.20	0.20	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	4.89	7.91	1.63	1.40	0.93	0.47	0.23	0.23	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	4.56	7.68	0.96	2.16	0.72	0.48	0.48	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	5.07	8.94	0.89	2.38	1.79	0.60	0.30	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	4.31	6.46	1.44	1.68	1.68	0.00	0.48	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	3.84	6.27	0.61	2.63	0.61	0.20	0.20	0.00	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	3.89	7.17	0.41	1.43	0.82	0.61	0.41	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	4.89	9.34	0.44	1.11	0.22	0.44	0.00	0.22	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	13.99	13.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	2.84	6.39	0.00	1.06	0.35	0.35	0.00	0.00	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	2.65	4.64	0.00	1.33	0.00	0.00	0.00	0.00	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	1.68	0.84	0.00	1.68	0.84	0.00	0.00	0.00	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	1.84	2.76	0.00	0.46	0.46	0.00	0.92	0.46	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	4.54	8.75	0.32	1.62	0.32	0.32	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	4.82	7.07	0.32	1.28	0.00	0.00	0.64	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	1.89	2.51	0.63	1.26	0.63	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	3.53	9.87	1.41	2.12	2.12	1.41	0.71	0.00	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	1.12	4.49	0.56	0.56	0.00	0.00	1.12	0.00	1.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	1.59	3.98	0.00	1.59	0.80	0.00	0.80	0.00	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	3.06	1.02	0.00	2.04	1.02	1.02	0.68	0.00	0.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	3.25	7.80	0.65	2.27	0.32	0.00	0.32	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	3.90	5.68	0.00	0.00	0.00	0.00	1.06	0.00	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	7.90	15.79	0.00	7.90	0.00	0.00	7.90	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	6.83	4.39	0.49	1.46	0.00	0.49	0.49	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	0.99	3.47	0.50	0.50	0.00	0.50	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	0.94	1.88	0.00	0.94	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	2.32	1.99	1.32	2.65	0.33	0.33	0.33	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	1.86	1.86	0.31	1.86	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	3.36	4.28	0.92	1.83	0.61	0.00	0.31	0.31	0.00
Adipocyte - breast, donor1	11376-118A8	37.06	25.34	6.18	6.02	3.01	6.34	1.27	2.69	1.27
Adipocyte - breast, donor2	11327-117E4	18.77	23.26	4.97	4.17	2.09	2.57	0.64	0.64	0.32
Adipocyte - omental, donor1	11473-119C6	53.31	34.35	7.76	6.49	4.71	7.51	1.53	3.94	1.02
Adipocyte - omental, donor2	11474-119C7	49.33	19.43	9.72	4.48	2.99	5.23	1.49	2.99	0.75
Adipocyte - omental, donor3	11475-119C8	70.67	36.17	14.74	8.04	5.02	8.37	1.34	2.68	0.67
Adipocyte - perirenal, donor1	11476-119C9	33.81	25.52	3.83	1.91	1.91	5.10	1.28	1.28	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	5.50	12.09	4.40	2.20	2.20	2.20	1.10	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	10.39	10.39	2.71	4.97	0.90	0.90	0.00	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	23.81	19.46	10.08	7.12	1.74	4.00	0.87	0.35	0.17
Adipocyte differentiation, day04, donor1	13019-139D4	20.54	11.73	7.82	1.37	2.54	3.91	1.76	0.39	0.59
Adipocyte differentiation, day04, donor2	13022-139D7	14.67	12.87	3.86	3.35	0.51	0.77	1.03	0.51	0.51
Adipocyte differentiation, day04, donor3	13025-139E1	19.51	13.38	4.18	5.02	1.67	3.07	0.56	1.12	0.84
Adipocyte differentiation, day04, donor4	13028-139E4	26.45	11.76	7.05	1.76	2.35	8.82	1.76	0.00	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	27.67	29.84	12.63	4.58	3.62	4.75	1.13	1.13	0.88
Adipocyte differentiation, day08, donor2	13023-139D8	22.92	19.37	5.16	3.87	1.94	3.55	0.32	1.61	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	17.60	16.00	6.93	2.13	1.07	6.40	1.07	1.07	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	19.48	28.93	3.90	3.90	0.56	3.90	2.23	1.11	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	17.88	16.22	5.41	4.99	2.08	4.57	0.83	0.42	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	17.08	19.34	3.77	6.28	0.50	4.27	0.75	1.00	0.50
Adipocyte differentiation, day12, donor3	13027-139E3	27.16	26.18	6.54	4.25	1.64	6.22	1.64	0.98	0.65
Adipocyte differentiation, day12, donor4	13030-139E6	17.05	17.35	4.87	1.22	2.44	2.44	0.00	1.83	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	13.92	16.80	3.31	4.20	2.65	1.99	0.22	0.44	0.22
Alveolar Epithelial Cells, donor2	11590-120G6	3.94	10.40	1.43	2.51	0.36	0.72	0.00	0.36	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	1.20	7.19	3.59	0.00	0.00	0.00	1.20	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	26.27	15.65	4.86	4.86	3.06	3.06	0.90	0.36	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	5.02	5.02	0.00	0.00	1.67	0.00	0.00	0.00	1.67
Amniotic Epithelial Cells, donor3	11694-123A2	16.85	16.44	3.49	7.60	2.67	2.47	0.62	0.21	0.21
Anulus Pulposus Cell, donor1	11248-116E6	21.51	21.86	3.55	4.12	4.23	2.06	1.03	0.23	0.00
Anulus Pulposus Cell, donor2	11463-119B5	20.33	25.23	3.67	3.18	3.92	2.45	0.00	0.00	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	19.77	19.32	5.39	3.15	2.70	3.59	0.00	0.45	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	21.27	21.27	5.21	3.47	3.47	1.74	0.00	1.74	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	12.84	10.70	0.00	4.28	2.14	2.14	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	19.43	18.23	6.28	5.68	1.20	1.79	1.20	1.20	0.90
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	21.50	18.97	7.59	7.59	2.53	5.06	2.53	3.79	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	18.48	14.52	2.64	1.98	1.98	1.32	0.66	0.66	1.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	19.82	22.74	4.22	5.20	1.30	2.60	0.32	1.30	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	20.39	17.48	11.17	6.80	2.91	2.91	0.97	0.97	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	20.79	21.97	2.97	4.16	2.97	4.16	0.00	0.59	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	19.59	19.96	4.52	3.77	3.01	3.01	1.13	0.00	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	22.50	21.77	5.81	6.53	2.18	2.90	2.18	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	10.03	12.54	5.02	0.00	1.25	6.27	2.51	2.51	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	34.43	23.72	7.25	6.42	2.80	4.78	1.15	1.48	0.49
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	17.74	27.30	2.73	9.55	2.73	5.46	1.36	0.00	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	19.90	12.52	2.71	4.37	2.41	2.26	0.15	1.06	0.45
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	28.93	25.18	8.57	5.89	2.14	2.14	1.61	0.54	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	28.15	17.00	7.56	7.56	4.16	3.40	0.38	1.89	0.76
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	21.65	22.99	3.47	9.09	2.41	3.21	1.34	1.34	0.53
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	35.12	29.26	5.85	7.80	3.90	2.93	0.00	2.93	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	24.38	17.91	6.80	3.32	4.48	3.98	0.83	0.83	0.83
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	10.81	16.81	3.60	1.20	0.00	7.20	0.00	3.60	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	17.70	14.16	0.00	14.16	0.00	7.08	0.00	3.54	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	21.44	16.47	7.72	4.97	2.57	2.57	1.20	0.69	0.86
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	8.39	8.39	0.00	12.58	0.00	0.00	4.19	0.00	4.19
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	17.96	16.99	4.37	6.31	2.43	1.94	0.97	0.49	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	20.11	20.49	9.49	4.55	3.42	3.42	0.76	1.52	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	27.86	29.07	3.63	7.27	1.21	1.21	1.21	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	17.67	21.09	3.99	6.27	2.28	1.71	1.14	0.00	1.14
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	18.38	16.25	4.28	4.70	2.78	4.28	1.07	0.43	0.64
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	13.42	18.58	2.84	3.61	2.32	1.29	0.52	0.52	0.52
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	21.11	19.24	4.69	5.63	2.35	2.35	0.47	0.47	0.94
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	19.61	22.83	6.11	7.72	3.22	3.22	0.32	1.93	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	16.41	12.13	1.43	4.28	2.85	2.85	0.00	1.43	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	17.55	18.13	4.68	0.58	2.92	1.17	0.58	0.58	1.17
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	23.48	22.88	6.92	4.22	4.82	5.12	0.30	2.11	0.60
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	13.07	15.44	3.56	1.19	0.00	1.19	1.19	1.19	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	22.38	23.90	5.09	6.10	1.02	3.05	0.00	0.00	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	23.18	21.14	6.37	3.06	3.06	2.80	0.76	1.53	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	10.17	17.15	3.18	6.99	2.54	0.00	1.27	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	22.44	19.85	4.75	6.04	2.59	4.75	0.00	0.43	0.86
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	24.77	18.42	6.35	5.08	1.91	3.60	0.21	1.06	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	14.50	11.89	2.90	4.35	1.45	2.90	0.58	0.58	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	26.45	17.95	7.56	1.89	0.94	5.67	0.00	0.94	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	25.77	21.70	6.78	3.73	2.37	2.88	0.68	1.36	0.68
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	9.27	6.95	0.00	2.32	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	31.69	12.68	8.45	8.45	4.23	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	21.66	19.73	7.93	4.50	2.79	2.36	0.86	1.50	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	14.44	21.06	4.81	3.61	0.60	1.20	0.00	0.60	1.20
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	21.14	12.39	5.83	5.83	2.19	2.19	0.73	0.73	1.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	22.76	20.23	9.20	5.06	2.76	3.91	0.92	0.92	0.92
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	22.95	5.10	0.00	5.10	5.10	5.10	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	16.53	10.42	3.56	2.54	1.78	4.07	0.25	2.03	0.76
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	24.57	22.30	7.02	3.72	3.10	3.51	0.62	1.03	0.62
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	18.36	17.75	3.67	3.98	3.06	2.75	0.61	0.61	0.61
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	25.33	24.38	6.21	3.82	3.82	2.87	0.96	1.91	0.96
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	21.73	17.52	5.99	5.10	2.66	3.33	0.22	1.11	1.33
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	19.84	10.68	1.53	4.58	4.58	1.53	0.00	1.53	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	18.28	13.29	4.43	3.88	2.77	1.11	1.11	0.55	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	20.12	19.07	5.30	3.18	2.65	2.91	1.32	0.26	0.79
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	16.36	13.45	2.18	3.63	0.73	2.18	0.36	1.09	0.73
Astrocyte - cerebellum, donor1	11500-119F6	55.51	18.67	5.77	4.54	6.02	6.63	1.11	2.70	0.49
Astrocyte - cerebellum, donor2	11580-120F5	28.07	14.21	9.24	2.74	2.74	3.59	1.03	1.71	0.68
Astrocyte - cerebellum, donor3	11661-122F5	11.54	14.68	2.73	2.10	3.15	2.10	0.63	0.63	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	21.61	23.36	3.83	2.44	4.53	1.39	4.88	0.00	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	16.99	22.65	5.18	4.85	2.91	1.62	2.43	0.49	0.65
Astrocyte - cerebral cortex, donor3	11392-118C6	8.95	11.63	2.83	2.24	1.79	1.34	1.19	0.15	0.15
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	17.20	4.01	3.44	0.23	3.44	0.92	2.52	0.11	0.46
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	14.03	4.26	3.26	1.00	3.38	0.88	1.63	0.25	0.88
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	10.81	3.76	1.02	0.91	3.30	0.46	1.93	0.11	1.59
Basophils, donor1	12241-129G9	1.05	0.26	0.00	0.00	0.78	0.00	0.00	0.00	0.26
Basophils, donor2	12242-129H1	1.80	0.00	0.36	0.00	1.08	0.00	0.00	0.36	0.00
Basophils, donor3	12243-129H2	3.53	1.62	2.06	0.73	0.59	0.59	0.00	0.29	0.15
Bronchial Epithelial Cell, donor1	11511-119G8	1.29	0.43	0.22	0.22	0.43	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	1.37	1.83	0.00	0.46	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	0.00	0.00	0.00	14.35	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	0.63	0.00	0.00	0.63	1.26	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	0.62	1.66	0.21	1.25	0.00	0.21	0.00	0.00	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	0.69	1.15	0.23	0.46	0.00	0.00	0.23	0.00	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	2.52	4.86	0.72	0.36	0.72	0.18	0.18	0.00	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	8.95	0.32	0.00	1.60	3.52	0.32	0.32	0.00	0.96
CD133+ stem cells - cord blood derived, pool1	12223-129E9	10.34	0.00	0.00	0.00	10.34	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	1.69	1.13	0.56	0.00	0.00	0.00	0.00	0.00	0.56
CD14+ Monocytes, donor2	11305-117B9	2.04	0.19	0.19	0.00	0.74	0.00	0.37	0.19	0.00
CD14+ Monocytes, donor3	11381-118B4	2.41	0.00	0.66	0.00	0.44	0.00	0.00	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	5.94	2.83	0.28	0.85	0.28	0.28	0.28	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	2.65	0.38	0.76	0.00	1.14	0.00	0.00	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	6.57	4.60	1.64	1.64	0.99	0.00	0.33	0.00	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	0.14	0.00	0.14	0.14	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	0.24	0.00	0.47	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	0.33	0.17	0.17	0.00	0.00	0.17	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	0.83	0.55	0.28	0.28	0.00	0.28	0.00	0.00	0.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	0.50	0.74	0.00	0.50	0.00	0.25	0.25	0.25	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	4.31	4.90	0.98	1.37	0.59	0.39	0.20	0.20	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	1.78	4.99	0.53	1.25	0.36	0.71	0.18	0.18	0.36
CD14+ monocytes - treated with BCG, donor3	11880-125C8	3.92	3.05	0.87	0.65	0.22	0.65	0.00	0.87	0.44
CD14+ monocytes - treated with Candida, donor1	11868-125B5	0.23	0.00	0.00	0.00	0.23	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	0.00	0.00	0.00	0.00	0.00	0.53	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	1.11	1.11	0.00	0.00	1.11	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	0.15	0.00	0.15	0.00	0.00	0.00	0.00	0.00	0.15
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	0.83	0.21	0.00	0.21	0.21	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	0.23	0.00	0.00	0.00	0.00	0.00	0.23	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	0.45	0.23	0.23	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	0.44	0.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	4.57	2.69	0.27	1.61	0.27	1.08	0.27	0.81	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	2.09	4.01	0.52	1.57	0.70	0.17	0.00	0.35	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	4.21	5.47	0.42	2.52	0.00	0.42	0.00	0.42	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	0.37	0.37	0.18	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	1.06	1.76	0.00	0.00	0.35	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	1.32	0.44	0.44	0.44	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	2.96	5.23	0.70	1.39	0.52	0.52	0.17	0.35	0.17
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	0.00	3.35	0.37	0.37	0.00	1.12	0.00	0.00	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	3.66	1.72	0.43	1.29	0.43	0.22	0.22	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	3.28	2.46	0.82	0.82	0.00	0.00	0.00	0.41	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	0.70	0.46	0.70	0.00	0.23	0.23	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	0.23	0.70	0.00	0.23	0.00	0.23	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	0.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	0.69	0.23	0.00	0.00	0.00	0.23	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	0.87	0.22	0.43	0.00	0.43	0.22	0.00	0.00	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	0.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.16
CD14+CD16- Monocytes, donor2	11799-124C8	0.17	0.00	0.00	0.00	0.17	0.52	0.00	0.00	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	0.67	0.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	0.00	0.26	0.00	0.00	0.26	0.00	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	0.00	0.22	0.22	0.00	0.00	0.00	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	0.42	0.42	0.00	0.00	0.00	0.21	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	2.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	0.68	0.00	0.68	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	2.07	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	0.00	0.00	0.54	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	0.70	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	1.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	1.32	2.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	1.64	0.00	0.00	0.00	0.82	0.00	0.00	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	0.73	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	2.02	0.00	0.00	0.00	1.01	0.00	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	7.27	9.70	1.62	0.81	0.40	0.40	1.21	0.00	0.40
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	7.59	13.18	2.40	1.60	1.20	0.40	0.80	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	5.02	1.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	6.18	0.00	0.00	0.00	2.81	0.00	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	14.28	1.88	1.50	0.00	1.50	1.13	1.88	0.00	1.50
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	8.57	2.25	1.80	0.45	3.38	0.45	1.35	0.00	2.48
CD4+ T Cells, donor1	11225-116C1	2.50	0.00	0.36	0.36	0.00	0.00	0.00	0.00	0.00
CD4+ T Cells, donor2	11306-117C1	0.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+ T Cells, donor3	11382-118B5	0.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	0.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	0.29	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	0.00	0.00	0.16	0.00	0.16	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	3.37	0.42	0.84	0.42	0.42	0.42	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	2.91	0.83	0.42	0.42	0.42	0.21	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	6.35	0.67	0.67	1.00	1.34	0.67	0.67	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	2.72	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	4.29	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	5.38	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	0.56	0.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	0.22	0.00	0.00	0.00	0.22	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	0.42	0.00	0.00	0.21	0.21	0.00	0.00	0.00	0.21
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	1.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	0.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	1.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	0.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	1.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	2.22	0.28	0.28	0.00	0.28	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	1.72	0.49	0.25	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	1.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	0.72	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	2.77	1.38	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	1.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells, donor2	11307-117C2	0.75	0.00	0.00	0.00	0.00	0.38	0.00	0.00	0.00
CD8+ T Cells, donor3	11383-118B6	0.00	0.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	0.00	0.00	0.00	0.00	0.00	0.23	0.00	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	0.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.70	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	18.28	20.11	5.48	1.83	5.48	1.83	5.48	1.83	0.00
Cardiac Myocyte, donor2	11605-120I3	40.52	35.08	8.40	7.41	3.46	3.95	0.49	0.49	0.00
Cardiac Myocyte, donor3	11686-122I3	27.68	28.41	11.05	7.89	4.63	3.26	0.63	0.21	0.32
Chondrocyte - de diff, donor1	11261-116G1	10.40	14.56	2.77	3.81	1.04	1.73	0.35	0.35	0.00
Chondrocyte - de diff, donor2	11338-117F6	13.15	19.19	2.13	3.20	0.71	0.71	0.36	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	13.20	20.03	4.21	4.21	1.59	1.59	0.46	0.80	0.11
Chondrocyte - re diff, donor2	11339-117F7	13.43	3.58	0.90	0.90	0.00	0.90	0.00	0.00	0.90
Chondrocyte - re diff, donor3	11411-118E7	10.51	16.58	2.43	6.07	0.81	0.81	0.81	0.00	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	16.75	15.72	1.95	2.87	5.05	2.18	2.07	0.34	1.15
Ciliary Epithelial Cells, donor2	11323-117D9	11.54	17.10	1.71	4.28	4.49	0.43	1.07	0.21	1.28
Ciliary Epithelial Cells, donor3	11399-118D4	10.97	19.29	3.89	3.36	2.74	0.97	1.59	0.35	1.15
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	20.36	16.87	5.32	4.49	3.39	2.66	0.37	0.28	0.00
Corneal Epithelial Cells, donor1	11526-119I5	0.66	0.44	0.00	0.22	0.00	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	0.26	0.00	0.00	0.00	0.26	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	1.98	0.66	0.33	0.33	0.33	0.17	0.17	0.00	0.17
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	0.95	2.21	0.95	1.26	0.32	0.32	0.32	0.00	0.63
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	3.45	0.00	0.00	0.00	3.45	0.00	3.45	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	1.62	1.40	0.32	0.97	0.43	0.00	0.00	0.11	0.11
Dendritic Cells - plasmacytoid, donor1	11228-116C4	6.83	0.00	0.00	0.00	1.71	0.00	0.00	0.68	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	5.22	0.00	0.65	0.00	3.26	0.00	0.00	0.00	0.65
Dendritic Cells - plasmacytoid, donor3	11385-118B8	5.81	0.00	0.00	0.00	3.39	0.00	0.00	0.48	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	3.84	5.00	1.33	0.83	0.00	1.00	0.17	0.17	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	2.93	3.52	0.00	0.59	0.00	0.59	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	2.55	4.52	0.28	1.41	0.00	0.57	0.28	0.00	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	3.15	3.93	0.39	0.00	0.00	0.00	0.00	0.00	0.39
Endothelial Cells - Artery, donor1	11264-116G4	13.09	10.47	3.78	2.91	2.62	1.45	0.87	0.00	0.29
Endothelial Cells - Artery, donor2	11341-117F9	15.06	27.06	4.71	8.23	2.12	2.35	0.47	0.00	0.47
Endothelial Cells - Artery, donor3	11413-118E9	4.56	6.31	1.23	2.10	0.70	1.23	0.70	0.35	0.18
Endothelial Cells - Lymphatic, donor1	11236-116D3	7.09	9.75	1.55	3.10	0.89	0.44	0.44	0.22	0.44
Endothelial Cells - Lymphatic, donor2	11317-117D3	10.65	11.56	1.83	2.13	3.04	0.91	0.30	0.30	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	6.20	8.46	1.13	1.41	2.26	0.56	0.28	0.00	0.85
Endothelial Cells - Microvascular, donor1	11265-116G5	2.97	5.05	0.30	2.38	0.30	0.30	0.30	0.00	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	5.21	5.21	1.56	0.52	0.00	1.04	1.04	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	1.42	1.56	0.57	0.28	0.99	0.00	0.00	0.14	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	8.00	9.60	0.40	1.20	0.80	0.80	0.40	0.00	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	5.24	6.29	0.00	1.57	1.05	0.52	0.00	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	14.66	17.77	1.74	5.96	1.99	1.24	0.25	0.12	1.37
Endothelial Cells - Umbilical vein, donor2	11324-117E1	8.04	13.04	2.39	1.96	1.74	0.87	0.65	0.00	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	12.70	15.02	2.44	1.83	1.83	0.61	0.49	0.37	0.85
Endothelial Cells - Vein, donor1	11267-116G7	0.00	0.00	0.00	0.00	2.28	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	2.10	6.29	0.00	1.40	0.70	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	2.98	4.87	0.94	1.10	1.10	0.16	0.16	0.00	0.31
Eosinophils, donor1	12244-129H3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	3.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	0.73	0.73	0.00	0.24	0.00	0.00	0.24	0.00	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	0.00	2.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	11.49	17.65	2.46	1.64	1.23	1.23	0.00	0.00	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	7.77	7.55	1.64	2.74	0.88	0.77	0.22	0.33	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	27.63	37.59	5.74	8.02	3.25	3.03	0.33	0.54	0.65
Fibroblast - Aortic Adventitial, donor1	11245-116E3	27.05	24.98	6.79	6.55	2.91	3.40	1.70	1.09	1.46
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	24.84	21.56	9.69	7.92	3.96	3.28	2.32	2.59	0.41
Fibroblast - Aortic Adventitial, donor2	11326-117E3	22.68	24.79	5.48	6.33	3.38	3.80	0.53	1.05	0.32
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	48.75	45.85	8.43	15.02	5.80	6.85	1.32	1.58	0.26
Fibroblast - Aortic Adventitial, donor3	11401-118D6	23.92	33.55	8.97	7.31	2.33	3.99	1.99	3.32	0.33
Fibroblast - Cardiac, donor1	11268-116G8	34.02	22.23	15.42	4.08	4.54	4.99	0.45	2.72	0.00
Fibroblast - Cardiac, donor2	11345-117G4	15.16	19.71	4.55	1.52	3.03	3.03	0.00	0.00	1.52
Fibroblast - Cardiac, donor3	11417-118F4	25.87	21.61	9.78	5.05	2.37	6.62	0.63	1.89	1.26
Fibroblast - Cardiac, donor4	11452-119A3	27.58	29.70	9.40	4.55	5.76	2.42	1.52	1.21	0.30
Fibroblast - Cardiac, donor5	11456-119A7	21.45	32.11	8.50	8.76	2.79	2.41	0.89	0.89	1.27
Fibroblast - Cardiac, donor6	11460-119B2	38.81	35.93	11.52	8.49	5.15	5.15	1.67	1.06	0.76
Fibroblast - Choroid Plexus, donor1	11492-119E7	20.50	14.47	3.35	4.42	3.48	2.55	0.40	0.27	0.40
Fibroblast - Choroid Plexus, donor2	11572-120E6	17.69	17.26	6.47	4.75	3.02	3.02	0.86	0.00	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	19.04	14.65	2.93	5.86	4.39	1.46	2.93	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	31.60	22.83	4.15	5.30	3.46	3.69	0.23	0.46	0.23
Fibroblast - Conjunctival, donor3	11692-122I9	30.19	39.52	5.77	10.18	5.43	2.04	0.51	0.17	0.34
Fibroblast - Dermal, donor1	11269-116G9	9.86	5.17	2.82	2.35	2.82	0.94	0.47	0.00	0.70
Fibroblast - Dermal, donor2	11346-117G5	7.55	5.66	0.00	0.94	0.47	1.42	0.94	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	9.43	5.08	1.57	2.90	2.78	1.45	0.85	0.00	0.60
Fibroblast - Dermal, donor4	11450-119A1	12.10	10.29	3.28	2.94	1.24	1.02	1.70	0.11	0.68
Fibroblast - Dermal, donor5	11454-119A5	14.31	13.43	3.49	3.31	1.92	1.40	2.62	1.05	2.09
Fibroblast - Dermal, donor6	11458-119A9	14.46	8.28	2.76	1.62	3.25	1.46	1.30	0.32	0.97
Fibroblast - Gingival, donor1	11237-116D4	15.41	8.33	3.54	3.33	1.67	1.25	1.04	0.00	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	23.84	22.79	5.50	3.67	2.62	3.14	1.57	1.05	0.79
Fibroblast - Gingival, donor2	11318-117D4	15.02	16.21	4.22	5.14	2.90	1.32	0.53	0.40	0.79
Fibroblast - Gingival, donor3	11394-118C8	18.66	15.18	5.90	2.61	1.93	1.64	1.26	0.10	0.39
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	54.02	34.28	12.47	8.31	8.31	11.43	0.00	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	58.68	41.94	23.44	11.28	3.88	14.98	0.53	2.64	0.70
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	27.44	22.76	6.86	5.30	2.49	3.12	2.18	1.09	0.94
Fibroblast - Gingival, donor6 (control)	11922-125H5	17.85	10.82	5.14	3.79	1.89	2.98	1.89	1.76	0.41
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	18.00	12.70	6.35	3.18	2.47	1.06	0.71	0.00	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	16.67	10.68	4.24	2.78	2.92	2.63	1.75	0.00	0.88
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	12.00	16.50	1.91	3.95	2.45	1.77	2.05	0.27	0.82
Fibroblast - Gingival, donor8 (control)	11926-125H9	15.25	12.94	4.17	3.51	1.54	2.52	1.43	1.10	0.99
Fibroblast - Gingival, donor9 (control)	11927-125I1	72.93	40.79	20.69	14.53	8.07	10.27	1.61	4.84	0.59
Fibroblast - Lung, donor1	11270-116H1	4.08	10.87	2.72	4.08	0.00	0.00	0.00	1.36	0.00
Fibroblast - Lung, donor2	11347-117G6	13.43	11.94	2.98	5.97	2.98	0.00	1.49	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	8.65	11.82	1.69	1.27	2.53	0.84	0.42	0.21	0.42
Fibroblast - Lymphatic, donor1	11506-119G3	21.66	10.00	3.33	5.00	2.50	3.33	0.00	0.83	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	29.37	11.19	4.20	2.80	1.40	1.40	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	7.00	5.04	2.80	3.08	0.28	1.12	0.00	0.56	0.00
Fibroblast - Mammary, donor1	11540-120B1	11.37	7.71	4.06	2.84	1.62	1.22	0.81	0.41	0.81
Fibroblast - Mammary, donor2	11620-122A9	3.99	0.00	0.00	7.99	3.99	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	11.91	11.91	0.00	5.96	5.96	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	14.35	12.22	3.10	2.52	1.36	1.36	0.97	0.39	1.36
Fibroblast - Periodontal Ligament, donor2	11319-117D5	19.87	21.39	4.55	3.79	3.64	1.52	0.76	0.61	0.30
Fibroblast - Periodontal Ligament, donor3	11395-118C9	24.78	12.85	7.96	4.28	3.37	2.45	2.75	0.61	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	27.10	14.12	8.40	3.82	3.82	3.43	0.38	1.14	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	22.68	12.96	9.45	6.21	2.16	5.94	1.62	1.08	0.54
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	53.12	29.81	18.79	5.91	3.60	10.79	1.16	3.60	0.58
Fibroblast - Pulmonary Artery, donor1	11250-116E8	63.34	42.67	12.49	11.50	10.72	9.95	0.22	2.21	1.33
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	36.78	21.34	8.53	5.69	2.64	5.08	0.20	1.22	0.20
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	5.35	4.68	2.00	0.67	0.67	0.67	0.00	0.67	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	15.02	12.26	5.54	4.35	3.95	0.40	0.40	0.40	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	12.50	9.72	2.78	3.97	1.39	1.59	1.39	0.60	0.60
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	27.89	14.92	5.15	3.91	2.66	3.02	0.71	0.36	1.07
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	33.11	20.69	6.31	5.52	3.94	4.53	1.77	0.59	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	15.34	11.43	5.42	2.41	4.21	2.71	1.50	0.90	1.20
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	29.36	23.43	6.91	5.29	3.13	4.64	2.37	0.76	1.08
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	12.65	9.11	6.83	3.04	0.76	1.77	0.25	0.76	0.25
Fibroblast - skin normal, donor1	11553-120C5	12.96	9.19	3.77	1.31	1.48	1.97	1.15	0.16	0.16
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	23.66	18.25	8.62	8.42	2.41	3.81	2.21	1.40	1.40
Fibroblast - skin normal, donor2	11561-120D4	25.22	22.30	5.83	3.62	2.51	5.12	0.90	1.21	0.70
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	22.37	12.69	5.14	6.35	1.51	3.02	2.42	1.21	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	40.93	26.35	9.28	8.62	4.23	6.30	1.24	1.41	0.33
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	108.55	71.80	22.57	12.65	10.60	11.45	0.34	2.39	0.51
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	9.52	5.58	3.28	2.30	1.31	0.00	0.66	0.66	0.66
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	7.78	7.99	2.45	1.81	2.02	0.75	0.64	0.75	0.32
Fibroblast - skin walker warburg, donor1	11554-120C6	21.42	16.53	3.54	4.05	2.36	2.36	0.17	0.51	0.34
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	6.43	5.65	2.04	2.20	0.63	0.63	1.25	0.31	0.16
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	0.00	44.32	22.16	0.00	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	0.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	0.35	0.52	0.17	0.35	0.35	0.00	0.00	0.00	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	1.56	1.82	0.26	0.78	0.26	0.00	0.00	0.00	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	1.02	1.28	0.00	0.51	0.26	0.00	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	9.95	6.89	0.77	2.30	0.77	2.30	0.77	0.77	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	9.57	4.47	1.28	0.64	2.55	1.28	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	4.28	1.71	1.43	1.14	0.29	0.86	0.57	0.29	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	3.31	0.28	0.28	0.55	1.10	0.00	0.00	0.00	0.55
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	5.94	3.20	0.91	2.51	1.83	0.46	0.00	0.00	0.23
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	4.76	1.39	1.39	2.38	0.59	0.20	0.00	0.00	0.59
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	0.79	1.06	0.53	0.53	1.06	0.00	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	4.89	3.91	0.98	1.63	1.96	0.33	0.65	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	4.42	0.88	0.44	0.44	0.00	0.44	0.44	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	14.41	5.51	2.54	2.54	1.70	1.84	0.28	0.28	0.42
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	7.88	4.93	1.60	1.35	1.11	0.25	0.37	0.12	0.37
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	7.79	4.03	2.69	0.81	0.00	0.81	0.54	0.27	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	11.65	7.31	3.47	2.73	1.61	0.87	0.74	0.25	0.87
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	7.06	4.84	2.08	1.25	1.11	0.83	0.55	0.28	0.42
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	10.37	3.66	1.42	2.44	1.22	0.41	0.81	0.20	0.61
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	11.18	6.85	4.11	2.28	1.60	0.46	1.14	0.23	1.14
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	6.85	5.11	1.62	1.99	0.75	0.50	0.75	0.12	0.87
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	9.62	3.93	5.46	2.19	1.53	0.22	1.97	0.22	0.44
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	14.48	12.11	2.36	1.77	0.59	0.89	1.48	0.30	1.77
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	11.60	9.54	1.75	1.91	1.75	0.79	0.16	0.16	0.48
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	16.98	11.62	4.47	4.24	1.34	1.79	0.45	0.67	1.12
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	17.34	17.34	5.04	3.83	2.02	0.81	1.41	0.00	1.21
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	14.93	15.61	2.88	2.88	1.87	1.02	2.54	0.00	1.36
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	19.33	13.57	3.28	4.61	2.57	3.10	1.51	0.80	2.04
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	29.55	25.18	4.89	4.27	1.77	1.35	1.56	0.52	3.43
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	32.11	20.83	2.73	2.56	1.71	0.85	2.73	0.51	2.90
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	15.16	16.16	3.65	3.21	3.43	1.55	1.00	0.22	1.22
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	18.30	16.22	4.16	5.07	3.33	1.83	1.58	0.08	1.50
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	21.85	15.52	3.47	4.29	2.65	2.04	1.02	0.00	1.23
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	21.04	16.09	5.57	2.48	3.71	0.83	1.03	0.21	0.83
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	17.41	18.22	3.80	3.11	3.92	0.81	0.92	0.35	1.04
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	14.34	11.84	4.17	4.00	2.50	1.00	1.33	0.33	1.50
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	16.97	14.77	3.09	2.42	5.73	1.76	2.42	0.66	1.54
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	24.35	16.97	4.92	1.84	4.43	1.35	1.97	0.37	1.48
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	16.86	15.24	2.76	2.92	3.08	0.97	1.62	0.32	1.13
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	27.90	20.21	7.06	1.28	1.28	1.92	1.60	0.32	0.96
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	17.53	14.97	3.22	2.65	4.26	1.42	1.04	0.28	0.66
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	13.44	7.75	3.01	1.74	2.53	0.79	1.27	0.00	0.79
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	20.98	19.16	0.91	4.56	3.04	1.22	1.22	0.00	0.91
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	15.79	12.65	3.35	2.30	3.45	1.15	1.67	0.42	1.25
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	13.61	14.05	2.63	2.85	2.63	0.66	0.88	0.22	0.44
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	13.47	14.59	3.37	4.21	3.65	2.24	0.84	0.28	1.40
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	17.87	11.94	3.33	3.33	1.76	0.74	1.48	0.28	0.93
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	8.02	8.29	3.21	2.14	1.07	0.53	0.53	0.00	0.53
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	12.70	11.02	2.45	2.30	2.91	0.92	1.22	0.61	1.22
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	12.57	12.05	1.94	1.42	2.72	1.17	1.55	0.00	0.78
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	10.84	11.93	1.90	3.52	3.25	0.27	0.54	0.27	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	17.70	19.36	4.42	4.98	4.79	1.11	1.29	0.55	0.74
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	17.98	20.18	4.17	3.29	4.61	1.75	0.44	0.00	0.44
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	23.80	21.82	5.95	12.89	5.95	0.00	0.00	0.00	0.99
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	15.70	18.07	3.83	4.35	2.24	0.79	0.53	0.26	0.66
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	15.94	19.17	3.83	4.84	1.41	1.82	1.21	0.20	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	26.94	33.04	3.56	5.85	1.27	1.27	0.51	1.02	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	1.99	0.40	0.80	1.39	1.39	0.00	0.00	0.00	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	3.85	0.46	0.46	0.46	1.23	0.15	0.00	0.15	0.00
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	4.71	1.43	0.20	1.23	1.43	0.20	0.20	0.00	0.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	2.50	0.63	0.31	0.94	1.56	0.31	0.31	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	2.83	0.85	0.28	2.83	0.28	0.00	0.28	0.28	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	2.77	0.46	0.00	1.38	0.92	0.00	0.00	0.46	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	2.47	2.47	0.00	2.47	0.00	2.47	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	4.25	0.39	1.55	2.71	1.16	0.39	0.00	0.00	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	6.42	0.00	0.00	9.63	1.60	1.60	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	5.22	0.00	1.74	3.48	1.74	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	3.91	2.28	0.33	2.28	0.00	0.65	1.30	0.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	6.59	2.06	0.41	3.29	2.06	0.41	0.82	0.41	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	3.33	3.33	6.66	3.33	0.00	3.33	3.33	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	6.15	3.08	0.28	2.80	1.68	0.84	0.28	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	6.54	3.27	2.29	1.96	1.31	2.94	0.65	0.00	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	10.07	1.68	2.52	2.52	1.68	0.84	0.84	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	10.81	4.45	1.27	3.18	0.64	1.27	0.32	0.32	0.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	6.45	2.38	2.04	1.36	0.68	0.00	0.00	0.00	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	6.26	8.35	2.09	0.00	2.09	2.09	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	8.59	4.01	2.29	2.29	1.72	0.57	0.57	0.00	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	8.88	5.62	1.48	2.07	0.59	0.59	0.59	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	5.08	1.69	1.69	3.39	0.00	1.69	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	12.43	7.87	1.66	2.90	1.66	0.83	0.00	0.41	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	6.90	6.21	1.61	2.53	1.15	1.61	0.46	0.23	0.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	10.54	10.54	10.54	0.00	5.27	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	7.69	5.77	1.54	4.61	0.77	0.00	0.00	0.00	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	8.15	8.48	0.65	0.98	1.30	0.33	0.33	0.00	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	8.03	5.35	3.34	6.02	1.34	0.00	0.00	0.67	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	16.18	11.56	1.54	4.62	3.08	0.77	0.39	0.00	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	22.59	13.01	4.45	7.19	3.77	2.40	1.03	0.68	1.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	14.91	4.97	2.48	7.45	2.48	0.00	2.48	0.00	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	19.82	8.97	3.30	4.25	0.94	0.00	0.00	0.00	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	22.33	15.09	3.62	4.83	7.24	0.60	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	15.26	10.17	1.53	1.02	2.54	0.00	0.00	0.51	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	12.76	15.55	1.99	4.39	2.79	1.20	1.20	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	15.79	13.32	2.47	4.93	3.95	0.99	0.00	0.00	1.97
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	12.98	11.80	2.36	2.36	1.18	0.00	1.18	0.00	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	19.84	9.34	5.25	6.42	2.92	1.75	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	11.41	11.85	2.63	2.19	1.32	0.00	0.00	0.00	1.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	19.50	23.74	5.93	5.09	4.24	0.85	2.54	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	25.07	24.47	7.16	4.78	4.18	1.79	1.19	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	12.62	17.47	3.88	2.43	1.94	5.34	1.94	0.49	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	7.99	3.42	3.42	1.14	3.42	2.28	1.14	1.14	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	9.98	16.63	2.91	2.91	1.25	2.08	0.42	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	5.62	7.87	1.12	5.62	2.25	0.00	2.25	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	77.07	36.47	24.10	16.18	8.88	15.86	0.63	4.76	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	23.39	18.80	5.85	7.52	3.34	5.01	0.00	2.09	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	10.91	18.68	2.55	2.09	1.97	0.93	1.39	0.46	0.70
Hep-2 cells mock treated, biol_rep2	11899-125E9	17.22	22.79	3.71	2.19	2.53	1.52	2.19	0.00	0.84
Hep-2 cells mock treated, biol_rep3	11900-125F1	9.56	17.75	2.05	0.68	2.28	0.91	1.14	0.00	0.68
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	11.37	19.13	2.19	2.40	1.53	0.87	3.06	0.11	1.31
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	14.61	20.85	2.79	2.36	1.29	2.15	1.72	0.21	0.86
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	11.84	14.42	2.15	1.08	3.66	1.08	0.65	0.22	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	6.60	15.07	1.74	0.87	0.87	0.62	1.12	0.25	0.87
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	7.55	15.10	0.69	1.20	1.20	1.20	0.69	0.17	0.17
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	5.13	8.01	1.60	0.64	1.60	0.96	1.28	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	6.16	15.67	1.12	2.80	0.56	0.00	0.56	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	5.19	4.33	0.87	2.16	0.00	0.87	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	7.93	21.15	2.64	10.58	10.58	2.64	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	9.88	11.64	3.17	2.12	1.41	0.71	0.00	0.35	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	7.27	8.72	2.91	2.18	2.91	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	9.79	16.61	3.15	4.37	1.92	1.40	0.52	0.35	0.17
Hepatocyte, donor1	11523-119I2	10.90	13.32	6.05	2.42	1.21	0.00	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	16.16	19.39	6.46	5.39	3.23	2.15	0.00	1.08	0.00
Hepatocyte, donor3	11684-122I1	14.72	16.57	3.68	1.23	1.84	5.52	0.61	0.61	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	2.61	1.31	0.00	0.65	1.31	0.00	0.00	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	12.76	25.34	3.32	6.12	1.05	1.22	0.87	0.52	0.70
Iris Pigment Epithelial Cells, donor1	11530-119I9	32.38	25.11	8.37	5.49	5.08	3.43	1.23	0.69	0.82
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	15.92	12.74	6.37	6.37	9.55	6.37	3.18	3.18	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	20.03	6.68	0.00	0.00	13.35	6.68	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	54.17	0.00	0.00	0.00	27.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	15.23	8.31	2.77	12.46	8.31	5.54	4.15	1.38	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	2.50	10.01	5.01	5.01	2.50	2.50	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	11.87	0.00	0.00	23.74	0.00	0.00	0.00	11.87	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	23.07	17.94	7.69	23.07	2.56	2.56	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	9.14	4.57	9.14	4.57	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	12.99	16.24	6.50	17.87	3.25	4.87	1.62	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	15.01	18.34	0.00	15.01	6.67	3.33	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	3.63	10.89	7.26	3.63	3.63	3.63	3.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	19.85	11.91	6.62	9.26	3.97	2.65	0.00	2.65	1.32
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	15.52	9.98	1.11	3.33	1.11	1.11	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	10.48	20.95	5.24	5.24	0.00	10.48	5.24	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	14.49	11.34	8.82	8.82	1.89	0.63	0.63	0.63	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	4.64	12.37	4.64	9.28	1.55	1.55	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	14.63	29.27	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	9.04	21.97	4.52	4.52	1.29	1.29	1.29	1.29	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	4.83	25.76	8.05	12.88	1.61	1.61	1.61	1.61	3.22
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	11.95	0.00	0.00	11.95	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	9.78	27.71	4.07	8.15	3.26	2.44	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	11.75	15.11	0.00	6.30	3.36	1.68	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	14.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	13.66	28.93	4.02	15.27	4.82	4.02	2.41	1.61	0.80
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	9.23	14.77	4.62	4.62	0.00	1.85	0.00	0.00	0.92
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	15.08	0.00	15.08	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	9.44	12.75	3.30	3.78	1.89	1.89	0.47	0.00	0.94
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	10.88	12.70	3.63	5.44	1.81	0.91	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	14.74	0.00	29.48	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	17.22	22.60	7.53	3.23	0.00	1.08	1.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	8.89	10.16	5.08	5.08	0.00	5.08	0.00	0.00	1.27
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	0.00	16.43	0.00	0.00	16.43	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	17.22	20.41	3.83	9.57	1.28	3.19	1.28	0.00	0.64
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	7.29	9.11	0.00	5.47	1.82	1.82	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	15.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	10.00	19.28	0.71	5.71	0.71	0.71	1.43	0.00	0.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	6.64	6.64	0.00	13.27	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	41.70	20.85	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	9.26	14.82	4.01	3.70	0.62	2.78	0.00	0.31	0.31
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	14.05	21.07	8.78	19.32	1.76	1.76	0.00	0.00	1.76
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	18.86	18.86	3.14	15.72	3.14	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	13.91	27.12	2.09	9.04	2.09	1.39	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	13.28	22.13	6.64	2.21	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	6.48	29.18	9.73	9.73	0.00	3.24	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	16.57	24.41	3.49	12.21	2.62	0.87	0.87	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	15.75	13.50	9.00	13.50	2.25	2.25	2.25	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	24.39	27.88	3.48	17.42	10.45	6.97	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	11.73	13.87	3.20	2.13	3.20	2.13	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	22.17	18.01	8.31	4.16	5.54	4.16	1.39	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	25.65	14.25	8.55	14.25	0.00	2.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	19.33	26.69	4.60	4.60	4.60	3.68	0.00	0.92	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	12.10	15.13	9.08	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	12.42	18.63	12.42	6.21	0.00	0.00	0.00	0.00	6.21
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	8.46	11.63	1.06	1.06	2.11	0.00	0.00	0.00	1.06
Keratinocyte - epidermal, donor1	11272-116H3	0.41	0.82	0.00	0.08	0.24	0.08	0.00	0.00	0.00
Keratinocyte - epidermal, donor2	11349-117G8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	0.38	0.09	0.09	0.09	0.19	0.00	0.00	0.00	0.00
Keratinocyte - oral, donor1	11251-116E9	9.19	4.54	1.48	2.27	1.93	0.23	0.11	0.00	0.11
Keratocytes, donor1	11527-119I6	26.48	11.69	6.88	1.03	3.78	5.85	0.34	0.34	1.03
Keratocytes, donor2	11607-120I5	3.52	4.69	1.17	0.00	0.00	0.00	0.00	1.17	0.00
Keratocytes, donor3	11688-122I5	21.54	22.13	6.92	3.36	3.56	2.96	1.98	1.19	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	2.20	4.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	19.42	19.42	3.24	7.55	4.31	2.16	2.16	1.08	2.16
Lens Epithelial Cells, donor2	11609-120I7	13.49	9.69	3.58	1.27	4.38	1.04	1.04	0.23	0.58
Lens Epithelial Cells, donor3	11690-122I7	19.58	30.78	6.56	5.15	6.26	3.43	3.03	0.71	1.01
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	4.15	3.32	1.19	1.30	0.95	0.71	0.24	0.00	0.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	2.79	1.95	0.28	0.56	0.84	0.00	0.00	0.00	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	4.09	5.04	0.94	0.94	1.42	0.47	0.31	0.00	0.47
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	3.23	2.15	0.54	2.15	1.08	0.54	0.00	0.00	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	3.15	2.84	0.00	1.26	0.32	0.00	0.32	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	2.59	2.48	0.86	1.19	0.00	0.22	0.00	0.00	0.11
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	5.34	6.98	1.64	1.64	1.23	0.82	0.41	0.00	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	0.51	2.28	0.00	0.00	0.76	0.51	0.25	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	2.67	3.38	0.14	0.84	0.28	0.00	0.42	0.14	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	4.35	2.77	0.79	0.40	0.79	0.00	1.19	0.00	0.79
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	1.74	2.52	0.58	0.58	0.58	0.39	0.39	0.19	0.78
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	1.30	2.04	0.19	0.19	0.19	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	2.79	3.48	1.05	1.05	0.00	0.35	0.35	0.00	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	2.62	2.86	0.95	0.72	0.72	0.00	0.48	0.00	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	2.33	1.92	0.69	0.41	0.55	0.27	0.00	0.14	0.41
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	2.77	6.47	0.92	0.92	0.62	0.31	0.62	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	2.49	2.18	0.31	0.31	0.62	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	2.74	2.38	0.37	0.91	0.73	0.18	0.00	0.00	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	5.59	0.99	0.66	0.99	0.33	0.00	0.99	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	1.46	2.34	1.17	0.88	0.00	0.00	0.59	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	1.74	4.23	0.50	1.00	0.00	0.00	0.00	0.25	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	3.39	2.42	0.97	0.00	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	4.04	2.69	1.08	1.08	1.35	1.08	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	3.03	4.24	0.76	1.51	1.21	0.30	0.61	0.30	0.61
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	3.63	1.56	2.59	0.52	0.52	0.52	0.52	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	5.23	6.49	0.84	1.05	1.05	0.42	0.42	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	2.41	2.56	0.15	0.75	0.60	0.00	0.15	0.00	0.15
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	5.50	5.50	0.69	1.38	0.69	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	3.01	3.20	0.56	0.38	0.75	0.19	0.56	0.00	0.75
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	1.48	2.12	0.53	1.06	0.42	0.42	0.32	0.00	0.11
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	3.88	3.88	0.97	1.45	0.48	0.48	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	2.32	2.98	1.32	0.99	0.33	0.66	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	2.48	2.85	0.25	0.50	0.87	0.12	0.12	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	5.18	6.29	0.74	0.37	0.74	0.37	0.74	0.00	1.11
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	2.72	1.98	0.49	0.99	0.74	0.25	0.49	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	1.65	2.75	0.27	0.82	0.27	0.27	0.14	0.14	0.14
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	1.93	4.50	0.64	1.61	0.96	0.32	0.00	0.00	0.96
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	3.35	5.17	0.61	1.22	0.91	0.00	0.30	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	5.46	4.48	0.42	1.68	1.12	0.70	0.14	0.00	0.42
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	5.69	2.13	0.00	0.36	1.42	0.00	0.36	0.00	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	0.48	2.91	0.97	0.48	0.48	0.48	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	2.33	1.40	0.62	0.00	0.47	0.16	0.00	0.00	0.31
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	3.94	3.22	1.43	0.36	0.72	0.36	0.36	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	2.29	2.94	0.65	0.98	0.98	0.00	0.33	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	1.18	1.18	0.24	0.00	0.24	0.24	0.00	0.00	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	5.82	3.96	1.24	0.50	1.24	0.00	0.12	0.12	0.25
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	3.07	1.54	1.28	0.51	0.77	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	1.49	3.28	0.30	0.60	0.30	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	49.85	13.60	4.53	2.27	0.00	4.53	4.53	2.27	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	37.59	19.95	7.67	0.77	3.84	4.60	0.00	2.30	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	29.69	15.59	6.68	4.45	1.48	3.71	0.74	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	25.81	18.19	2.96	2.12	3.81	2.54	1.27	1.27	0.85
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	30.95	19.69	4.22	3.52	1.41	4.22	0.70	1.41	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	24.28	20.55	5.60	5.60	1.87	2.80	0.93	0.00	0.93
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	18.03	11.34	2.06	0.52	0.52	0.00	0.52	0.52	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	22.60	11.89	5.95	2.38	1.19	1.19	1.19	0.00	1.19
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	31.21	21.26	5.65	3.17	2.94	3.85	1.36	0.45	0.23
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	39.55	29.37	8.72	4.07	2.91	4.94	0.87	1.45	0.29
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	36.91	17.56	10.80	2.25	3.60	5.40	1.35	0.45	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	36.99	25.47	7.18	2.98	4.06	3.93	0.54	1.35	0.54
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	31.32	18.49	6.16	0.00	2.57	2.05	0.00	1.03	1.03
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	48.69	33.17	10.94	3.88	3.88	3.88	1.06	0.71	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	42.64	23.99	8.66	4.00	1.33	2.67	0.67	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	23.94	19.87	4.58	0.51	1.02	4.08	1.53	2.04	1.02
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	46.16	30.42	11.74	4.80	3.47	4.80	1.60	0.80	1.07
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	41.57	29.66	10.96	4.53	3.59	4.91	1.13	0.76	0.38
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	28.22	13.50	3.07	2.45	2.45	2.45	1.84	1.84	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	48.93	21.20	9.79	5.71	3.26	3.26	1.63	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	45.61	27.28	9.58	3.12	3.33	4.16	0.83	1.67	0.62
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	36.15	25.50	3.92	3.64	3.64	2.52	1.40	1.40	1.12
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	31.94	17.52	16.49	4.12	3.09	3.09	1.03	1.03	2.06
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	42.67	25.55	13.35	3.48	5.23	4.06	1.45	2.61	0.58
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	36.77	23.32	5.38	0.90	3.29	2.09	0.60	1.79	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	49.24	23.79	10.51	3.32	3.87	6.64	2.21	2.21	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	36.76	26.16	7.78	2.47	2.47	2.12	0.71	0.71	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	32.45	15.49	4.43	2.95	2.21	4.06	0.37	0.37	0.37
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	31.08	12.66	4.61	2.30	9.21	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	31.47	25.71	9.98	3.84	2.69	3.07	0.00	2.30	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	21.51	14.72	5.10	2.83	0.57	1.13	0.57	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	19.69	18.05	5.74	1.64	1.64	4.92	0.00	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	25.76	15.82	6.33	3.62	4.07	2.71	0.90	0.90	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	26.57	12.93	5.03	2.87	2.15	2.15	0.00	0.72	0.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	38.84	22.41	7.47	2.24	2.24	1.49	0.00	0.00	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	27.13	18.21	3.72	2.23	3.72	2.97	0.37	0.37	0.37
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	33.17	21.11	4.74	4.74	3.02	4.74	0.00	0.86	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	19.69	12.84	6.85	1.71	2.57	2.57	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	34.98	16.99	10.33	2.67	5.33	1.67	0.67	1.00	0.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	33.18	22.32	3.62	1.81	3.02	2.41	0.60	0.60	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	32.71	13.51	5.69	1.42	1.42	2.84	1.42	1.42	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	31.62	19.59	8.59	2.75	3.44	4.12	1.03	0.34	0.69
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	26.84	11.27	3.22	4.29	3.76	1.61	1.07	1.07	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	22.22	16.83	7.41	3.37	5.39	1.35	0.00	0.67	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	33.71	19.63	7.41	2.59	3.33	0.74	0.37	1.11	1.11
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	26.75	12.79	6.98	2.33	4.65	1.16	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	41.25	12.69	7.40	1.06	2.12	3.17	1.06	1.06	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	29.61	18.01	8.80	4.00	3.20	1.60	0.40	1.60	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	28.35	15.26	5.09	1.45	3.63	4.36	0.73	1.45	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	31.43	23.00	13.03	5.37	3.83	1.53	0.00	1.53	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	26.64	23.68	5.92	2.96	2.96	1.97	0.49	0.99	0.49
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	21.64	16.00	6.59	0.94	4.70	0.94	0.00	1.88	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	39.72	26.65	7.54	2.51	4.02	2.01	0.00	1.51	0.50
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	31.99	16.67	8.11	3.15	0.00	3.15	2.70	0.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	18.93	17.21	1.72	3.44	5.16	3.44	0.00	0.00	3.44
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	28.50	22.71	8.91	4.45	3.12	1.78	0.45	1.34	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	28.15	29.72	9.78	3.91	3.52	3.91	0.78	0.39	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	32.99	19.13	5.28	1.98	3.30	0.66	0.00	0.66	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	38.40	24.91	7.78	3.11	5.19	2.59	0.52	1.04	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	46.38	22.32	7.44	6.56	3.50	5.25	0.00	1.31	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	27.96	20.13	5.59	1.12	5.59	1.68	1.12	0.56	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	32.24	21.64	7.51	3.53	3.09	2.65	1.77	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	36.64	20.83	7.33	2.31	3.47	3.47	2.70	0.39	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	34.94	21.77	6.08	4.56	4.56	2.53	0.51	1.52	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	43.74	21.15	5.29	3.36	5.29	1.44	0.96	0.00	0.48
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	34.59	22.66	5.17	4.37	1.99	2.78	0.40	0.80	0.40
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	39.50	18.84	3.04	1.82	3.04	2.43	1.22	1.22	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	25.59	22.83	6.92	0.69	1.38	5.53	2.08	1.38	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	33.44	23.94	9.12	2.66	4.56	3.80	0.76	0.76	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	29.44	17.56	7.75	2.07	2.58	3.61	2.58	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	29.63	12.09	6.65	0.60	1.21	1.21	0.60	0.60	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	39.93	21.23	8.87	2.54	3.17	3.49	3.17	0.63	0.63
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	29.32	12.79	4.26	2.13	1.60	1.07	0.53	1.60	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	26.43	15.52	9.19	1.15	2.30	0.57	1.72	1.15	1.15
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	26.23	15.94	9.26	7.71	2.57	2.06	1.03	1.54	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	20.51	19.81	4.95	3.54	2.83	2.83	0.71	2.83	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	28.94	13.62	4.54	3.40	2.27	2.84	2.27	0.00	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	31.20	17.06	8.74	5.41	1.25	2.50	1.66	0.42	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	16.44	19.58	3.92	0.78	1.57	1.57	1.57	0.00	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	32.57	12.94	5.85	3.34	2.92	0.84	1.25	1.25	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	34.85	16.73	6.50	2.32	2.79	4.18	0.00	1.86	0.46
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	18.06	12.71	2.68	2.01	0.00	3.35	0.00	1.34	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	30.47	21.39	4.81	2.14	3.74	2.14	1.60	1.60	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	26.67	9.70	6.06	1.62	3.23	2.02	0.00	0.81	0.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	23.86	14.68	4.59	1.84	1.84	0.92	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	31.12	20.45	7.11	0.89	0.89	1.78	0.89	0.89	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	34.19	14.25	8.55	1.14	2.28	1.71	2.28	2.28	0.57
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	20.71	15.34	1.53	1.53	1.53	1.53	0.77	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	25.72	13.13	5.47	2.74	1.09	3.28	0.00	1.09	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	24.05	16.04	4.45	4.01	0.00	3.12	0.00	1.78	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	28.34	14.30	4.42	2.60	3.90	2.08	0.26	1.56	0.78
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	28.51	13.26	3.32	3.98	1.33	0.66	1.33	3.98	0.66
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	31.18	20.79	2.08	4.16	2.08	4.16	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	2.28	0.68	0.23	0.23	0.23	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor2	11313-117C8	0.55	0.92	0.00	0.55	0.37	0.00	0.00	0.00	0.18
Macrophage - monocyte derived, donor3	11389-118C3	2.75	1.31	0.00	0.52	0.26	0.00	0.13	0.26	0.26
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	0.53	1.06	0.00	1.06	0.53	0.00	0.00	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	3.80	4.75	0.32	1.27	0.79	0.32	0.95	0.00	0.00
Mallassez-derived cells, donor3	11930-125I4	2.36	2.36	0.14	0.14	0.28	0.14	0.14	0.00	0.00
Mammary Epithelial Cell, donor1	11273-116H4	0.30	0.60	0.00	0.10	0.10	0.00	0.00	0.00	0.00
Mammary Epithelial Cell, donor2	11350-117G9	0.00	0.29	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mammary Epithelial Cell, donor3	11422-118F9	0.50	0.25	0.00	0.00	0.00	0.00	0.00	0.00	0.25
Mast cell - stimulated, donor1	11487-119E2	179.65	6.78	23.05	0.68	3.39	15.59	12.88	19.66	42.71
Mast cell, donor1	11563-120D6	98.73	22.93	26.82	4.76	13.41	18.38	6.16	8.33	9.52
Mast cell, donor2	11565-120D8	63.60	14.26	21.10	1.19	6.54	5.05	1.49	4.75	0.30
Mast cell, donor3	11566-120D9	104.91	24.31	29.27	5.63	11.26	7.88	2.70	6.08	2.48
Mast cell, donor4	11567-120E1	69.50	16.13	21.27	3.55	10.11	7.45	1.60	3.19	0.71
Mast cell, expanded and stimulated, donor5	11940-126A5	72.86	27.50	15.08	5.21	6.99	9.76	7.65	3.66	8.43
Mast cell, expanded and stimulated, donor8	11942-126A7	27.43	11.09	2.92	2.33	5.84	3.50	1.75	0.58	9.92
Mast cell, expanded, donor5	11939-126A4	81.91	25.93	17.55	3.33	7.23	11.13	4.70	4.24	3.56
Mast cell, expanded, donor8	11941-126A6	34.31	22.43	9.54	2.34	4.85	5.36	3.01	3.85	1.67
Melanocyte - dark, donor1	11502-119F8	3.98	4.68	0.99	1.29	1.09	0.20	0.60	0.10	0.80
Melanocyte - dark, donor2	11582-120F7	37.72	35.30	10.73	9.00	7.61	4.50	0.00	1.04	2.08
Melanocyte - dark, donor3	11663-122F7	6.74	6.30	1.45	1.30	2.61	0.43	1.23	0.22	0.22
Melanocyte - light, donor1	11274-116H5	6.58	4.47	2.12	0.47	1.18	0.24	0.94	0.24	0.47
Melanocyte - light, donor2	11351-117H1	8.87	3.41	0.00	0.00	1.36	0.68	1.36	0.00	0.00
Melanocyte - light, donor3	11423-118G1	2.60	6.07	1.73	0.87	0.00	0.87	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	9.48	8.85	1.56	1.56	2.19	0.42	1.15	0.10	0.42
Melanocyte, donor2 (MC+2)	12739-135I3	7.80	14.52	1.08	1.61	3.23	1.34	0.81	0.00	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	20.89	17.41	2.68	1.87	3.75	1.34	1.07	0.27	0.80
Meningeal Cells, donor1	11493-119E8	18.86	12.16	2.23	1.86	2.11	1.24	0.99	0.50	0.50
Meningeal Cells, donor2	11573-120E7	26.41	14.97	7.48	3.08	4.84	3.52	0.00	2.20	0.44
Meningeal Cells, donor3	11654-122E7	13.61	9.05	2.12	2.04	3.26	2.28	0.57	0.33	1.30
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	21.67	17.96	5.13	4.56	4.85	2.85	0.57	0.57	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	22.14	28.48	3.72	5.74	2.62	3.32	1.61	1.71	1.21
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	13.14	13.14	3.94	1.31	0.00	3.94	0.00	2.63	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	3.92	1.31	1.31	1.31	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	8.61	5.74	0.72	2.87	0.00	0.72	0.72	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	49.34	37.69	8.68	5.29	5.29	4.24	1.48	1.69	0.85
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	45.24	23.62	11.06	6.03	4.02	5.53	2.01	1.51	1.51
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	13.40	8.35	2.42	3.08	1.76	1.54	0.44	0.00	0.22
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	5.11	7.31	1.46	1.46	1.46	1.46	0.73	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	5.32	9.41	1.23	2.05	0.82	0.82	1.02	0.20	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	67.04	37.67	10.80	13.57	6.79	5.96	0.55	2.22	0.14
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	17.84	15.98	1.86	4.09	2.23	1.49	0.00	0.74	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	74.87	82.10	15.26	13.03	9.60	9.60	1.18	2.50	0.66
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	19.58	11.28	3.86	2.08	3.86	2.67	0.00	0.00	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	7.01	11.68	0.00	0.00	2.34	0.00	0.00	2.34	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	6.40	13.45	1.92	5.12	2.56	0.00	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	6.73	8.51	2.48	2.84	1.06	0.35	0.71	0.00	1.06
Mesenchymal stem cells - hepatic, donor0	11218-116B3	63.80	80.68	20.95	10.32	6.25	6.57	0.31	1.25	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	10.16	13.79	3.63	7.98	2.18	1.45	0.73	0.73	0.00
Mesothelial Cells, donor1	11247-116E5	4.77	7.69	0.27	2.92	1.59	0.53	1.06	0.00	0.27
Mesothelial Cells, donor2	12156-128G5	2.50	7.51	3.00	2.50	1.00	0.50	0.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	7.66	11.27	1.23	2.38	1.30	0.51	0.94	0.14	0.14
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	0.00	0.00	1.35	0.00	0.00	0.00	1.35	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	1.23	0.99	0.00	0.00	0.49	0.00	0.49	0.00	0.49
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	2.36	0.29	0.29	0.29	0.59	0.00	0.29	0.00	0.59
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	6.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	0.31	0.00	0.31	0.00	0.00	0.00	0.31	0.00	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	1.24	0.62	0.00	0.21	0.21	0.21	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	1.50	1.00	0.00	0.50	0.50	0.50	0.50	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	0.00	0.00	0.47	0.00	0.00	0.93	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	0.81	0.20	0.41	0.00	0.00	0.20	0.00	0.00	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	2.38	0.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	0.00	0.88	0.88	0.88	0.00	0.00	0.00	0.00	0.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	0.38	0.38	0.00	0.00	0.38	0.00	0.38	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	1.32	2.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	0.64	0.21	0.00	0.00	0.21	0.00	0.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	0.00	0.92	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	0.89	0.00	0.30	0.30	0.60	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.68
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	0.75	0.50	0.25	0.75	0.25	0.00	0.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	0.48	0.71	0.00	0.48	0.48	0.24	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	0.55	0.00	0.00	0.00	0.55	0.55	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	0.92	0.23	0.00	0.69	0.46	0.00	0.23	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	1.26	0.42	0.42	0.00	0.63	0.00	0.21	0.00	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	0.61	0.82	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	0.86	0.43	0.21	0.00	0.00	0.21	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	0.44	0.00	0.44	0.22	0.44	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	0.44	0.44	0.22	0.44	0.22	0.22	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	0.00	0.00	0.51	0.00	0.00	0.51	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	1.36	0.82	0.27	0.00	0.00	0.27	0.00	0.00	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	0.88	0.29	0.59	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	0.00	0.00	1.09	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	0.48	0.96	0.00	0.48	0.00	0.00	0.48	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	0.80	0.80	0.00	0.80	0.00	0.00	0.00	0.00	0.80
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	1.00	0.00	0.00	0.00	1.00	1.50	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	26.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	2.04	0.00	2.04	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	2.19	0.00	0.00	0.44	0.44	0.44	0.00	0.00	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	3.31	1.10	1.10	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	2.56	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	1.74	1.24	0.00	0.00	0.25	0.50	0.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	2.09	0.00	0.70	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	6.63	0.00	0.00	0.00	0.00	2.21	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	1.71	0.34	0.00	0.34	0.34	0.68	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	0.44	0.00	0.44	0.00	0.44	0.44	0.00	0.44	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	0.71	0.36	0.00	0.00	0.36	0.00	0.00	0.00	0.36
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	0.84	0.28	0.00	0.56	0.00	0.00	0.28	0.00	0.28
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	0.42	1.66	0.83	0.00	0.83	0.00	0.42	0.00	0.83
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	1.75	0.58	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	1.81	0.90	0.30	0.30	0.60	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	1.25	0.00	0.42	0.42	0.83	0.42	0.42	0.42	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	0.00	0.00	0.00	1.85	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	2.28	0.00	0.00	0.57	0.00	0.57	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	0.83	0.14	0.41	0.00	0.41	0.00	0.14	0.14	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	0.26	0.00	0.00	0.52	0.26	0.26	0.26	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	2.57	0.00	0.00	0.43	0.86	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	0.64	0.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	2.14	0.27	0.00	0.27	0.27	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	2.99	1.50	0.00	1.20	0.30	0.60	0.90	0.00	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	1.84	0.14	0.42	0.28	0.28	0.14	0.28	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	0.64	0.00	0.00	0.32	0.32	0.00	0.64	0.00	0.32
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	2.21	0.00	0.22	0.44	0.00	0.22	1.11	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	1.14	0.38	0.00	0.00	0.00	0.00	0.38	0.00	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	0.85	0.28	0.00	0.57	0.57	0.57	0.28	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	1.72	0.49	0.25	0.74	0.49	0.74	0.49	0.00	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	2.61	0.00	0.65	0.00	0.00	0.00	1.30	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	4.12	0.88	0.29	1.47	0.29	0.59	0.59	0.00	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	5.19	0.86	0.86	0.86	0.86	0.00	0.29	0.00	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	4.12	2.89	0.82	0.41	0.82	0.00	0.82	0.00	0.82
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	2.68	0.89	0.00	0.00	0.30	0.00	0.89	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	0.33	0.00	0.00	0.00	0.33	0.33	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	0.00	0.00	0.00	0.00	0.00	0.00	1.05	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	0.20	0.00	0.00	0.00	0.20	0.00	0.00	0.20	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	0.93	0.00	0.00	0.00	0.00	0.00	0.93	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	0.75	0.38	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	0.00	0.53	0.00	0.53	0.00	0.53	0.27	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	0.34	0.11	0.00	0.00	0.23	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	0.00	0.00	0.00	0.00	0.74	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	0.37	0.00	0.37	0.37	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	0.53	0.53	0.00	0.53	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	1.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	0.42	0.00	0.42	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	4.09	1.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	0.64	0.00	0.00	0.00	0.00	0.64	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	0.81	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	4.53	3.02	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	5.71	11.42	5.71	0.00	5.71	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	13.05	6.52	0.00	3.26	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	0.00	4.75	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	0.00	25.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	10.77	7.54	2.80	2.59	1.29	1.08	0.65	0.00	0.22
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	7.32	5.23	1.57	3.66	1.05	1.57	1.05	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	11.35	14.68	2.67	2.67	0.67	0.00	0.00	1.33	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	7.51	16.69	1.25	2.09	1.25	1.67	0.42	0.00	0.42
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	11.03	9.51	1.90	7.42	2.85	1.90	1.52	0.57	0.76
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	20.75	25.53	6.38	3.19	3.19	4.79	0.00	1.60	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	11.56	13.60	5.44	4.08	0.68	1.36	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	14.70	14.70	1.84	5.51	5.51	3.68	3.68	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	18.42	20.09	6.70	7.53	0.42	1.67	0.00	0.84	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	13.48	10.46	2.09	6.04	1.16	1.86	0.23	0.23	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	16.48	24.86	2.97	8.11	0.81	2.97	0.54	1.62	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	21.23	16.40	5.26	3.36	2.31	4.84	1.47	2.73	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	22.27	44.54	11.13	22.27	11.13	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	14.89	13.40	1.99	8.44	1.49	2.98	0.50	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	12.18	11.37	4.33	4.87	4.33	1.89	1.08	1.89	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	15.87	15.87	3.63	6.80	2.95	2.72	0.00	1.59	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	15.19	35.11	3.10	7.84	2.29	2.12	0.49	1.63	0.33
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	25.52	22.42	3.46	5.10	4.01	2.92	0.73	1.64	0.36
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	15.38	27.05	2.65	5.83	2.65	2.12	0.53	0.53	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	7.20	15.01	0.00	3.60	1.20	1.80	0.00	0.60	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	12.80	11.49	1.97	8.86	3.61	1.31	1.31	0.98	1.64
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	17.24	19.03	5.04	7.32	1.79	2.93	0.65	1.30	0.81
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	21.52	20.64	5.12	3.17	3.00	5.12	0.35	1.23	0.53
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	16.17	21.10	4.92	7.03	1.41	3.52	0.00	1.41	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	15.17	19.31	0.92	11.49	4.14	0.92	0.00	0.46	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	17.03	36.63	7.07	11.89	1.29	1.93	0.96	0.32	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	14.83	17.59	5.52	8.62	4.83	4.48	1.72	1.03	0.69
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	22.76	27.81	10.11	0.00	2.53	0.00	2.53	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	19.16	20.27	3.12	4.90	2.23	4.23	0.45	2.67	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	15.67	19.05	2.12	7.62	0.42	1.69	0.85	1.27	0.85
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	9.97	9.73	1.90	7.60	0.47	0.71	0.47	0.47	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	18.03	33.48	3.86	12.88	1.29	3.43	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	81.25	36.11	9.03	18.06	18.06	18.06	9.03	9.03	18.06
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	14.00	28.66	2.67	7.00	1.33	2.67	0.33	1.33	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	7.21	16.23	3.16	2.71	0.90	5.41	0.00	1.35	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	7.94	16.67	1.59	5.16	1.19	0.40	0.79	3.97	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	8.36	19.50	1.86	0.93	0.00	0.93	0.00	0.93	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	17.41	20.81	3.03	12.49	2.65	2.27	1.51	0.76	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	15.64	24.44	2.61	6.52	1.30	1.96	0.98	1.30	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	9.15	33.12	1.74	2.18	1.31	3.49	0.44	0.44	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	14.02	16.73	3.17	2.26	0.45	2.26	0.00	2.26	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	10.58	25.58	0.88	7.94	2.65	0.00	0.88	0.00	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	10.64	23.93	1.33	7.98	0.66	1.99	0.00	1.33	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	13.39	24.31	1.98	8.43	0.99	2.48	0.50	1.98	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	7.27	29.09	1.53	4.98	0.38	1.15	1.15	0.77	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	14.82	25.10	3.33	13.91	1.81	3.93	1.21	1.21	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	12.82	17.24	2.87	5.53	0.88	2.43	0.22	0.88	0.88
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	12.20	40.66	3.39	4.74	1.36	2.03	1.36	1.36	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	25.55	45.99	15.33	5.11	5.11	0.00	0.00	5.11	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	14.02	34.14	5.49	12.80	3.05	1.83	0.61	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	6.61	13.53	1.57	5.35	2.52	0.94	0.31	0.63	0.63
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	6.36	20.88	1.82	6.66	1.51	2.12	0.30	0.30	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	12.66	26.90	3.16	10.28	1.58	1.58	1.58	1.58	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	22.67	18.14	4.53	5.67	4.53	2.27	1.13	0.00	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	20.23	35.41	5.06	10.12	10.12	0.00	0.00	20.23	0.00
Myoblast, donor1	11241-116D8	15.28	12.30	3.85	2.61	3.11	3.48	0.99	0.87	0.99
Myoblast, donor2	11322-117D8	15.73	14.77	4.79	3.64	2.69	4.03	1.15	0.96	0.38
Myoblast, donor3	11398-118D3	27.24	23.88	9.42	6.73	5.89	9.25	1.35	4.37	1.68
NK T cell leukemia cell line:KHYG-1	10777-110G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Natural Killer Cells, donor1	11230-116C6	6.46	0.62	0.00	0.00	0.92	0.31	0.00	1.23	0.31
Natural Killer Cells, donor2	11311-117C6	6.03	0.30	0.60	0.00	0.90	0.00	0.00	0.30	0.00
Natural Killer Cells, donor3	11387-118C1	8.10	0.92	0.55	0.00	1.10	0.37	0.18	0.37	0.18
Neural stem cells, donor1	11275-116H6	81.30	26.13	20.32	6.53	6.53	10.16	5.44	3.27	2.90
Neural stem cells, donor2	11352-117H2	94.36	36.59	13.48	3.85	7.70	11.55	1.93	0.00	3.85
Neurons, donor1	11494-119E9	22.76	21.62	5.69	0.00	2.28	2.28	0.00	1.14	1.14
Neurons, donor2	11574-120E8	18.71	18.27	4.40	3.52	5.06	0.88	0.66	0.66	0.44
Neurons, donor3	11655-122E8	4.11	9.87	2.47	2.47	1.64	1.64	0.00	0.82	1.64
Neutrophils, donor1	11233-116C9	0.93	0.00	0.00	0.00	0.00	0.00	0.00	1.86	0.00
Neutrophils, donor2	11314-117C9	8.70	0.00	0.00	0.00	0.00	0.00	2.90	0.00	0.00
Neutrophils, donor3	11390-118C4	1.83	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	36.10	34.67	5.34	6.65	6.77	1.90	0.71	0.59	0.36
Nucleus Pulposus Cell, donor2	11409-118E5	13.02	20.84	3.26	3.91	3.58	1.30	0.98	0.65	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	22.46	21.06	7.22	5.82	4.61	3.21	0.80	0.80	0.60
Olfactory epithelial cells, donor1	11933-125I7	45.29	37.44	11.43	5.92	5.64	6.61	1.24	1.51	1.79
Olfactory epithelial cells, donor2	11934-125I8	31.12	27.79	8.68	5.36	4.05	3.62	1.45	1.45	0.87
Olfactory epithelial cells, donor3	11935-125I9	86.72	53.80	21.57	7.60	6.47	11.12	1.14	4.31	0.34
Olfactory epithelial cells, donor4	11936-126A1	24.93	34.67	6.53	7.89	2.43	3.02	1.07	0.49	0.49
Oligodendrocyte - precursors, donor1	11496-119F2	16.85	34.91	7.22	4.81	1.20	2.41	0.00	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	16.38	22.33	3.62	5.74	2.34	1.91	0.43	0.64	0.43
Osteoblast - differentiated, donor2	11353-117H3	9.14	8.00	3.43	6.86	0.00	1.14	0.00	1.14	0.00
Osteoblast - differentiated, donor3	11425-118G3	13.66	14.90	2.48	3.10	1.24	1.86	0.62	0.00	0.62
Osteoblast, donor1	11277-116H8	5.67	8.40	1.56	2.35	1.37	1.17	0.20	0.00	0.39
Osteoblast, donor2	11354-117H4	21.77	24.58	1.40	6.32	6.32	1.40	1.40	0.00	0.00
Osteoblast, donor3	11426-118G4	15.64	17.77	3.91	4.80	2.31	2.31	0.36	0.71	0.36
Pancreatic stromal cells, donor1	11249-116E7	24.43	22.41	5.73	6.82	4.72	4.21	0.93	0.34	0.25
Pericytes, donor1	11491-119E6	7.01	2.56	1.89	0.89	1.67	0.89	0.22	0.11	0.22
Pericytes, donor2	11571-120E5	9.73	5.21	1.81	1.13	1.58	1.13	0.23	0.91	0.00
Pericytes, donor3	11652-122E5	19.53	18.31	5.70	7.12	2.03	3.66	0.61	0.61	0.41
Perineurial Cells, donor1	11499-119F5	29.72	17.41	9.83	4.97	6.44	2.26	0.90	0.45	0.45
Perineurial Cells, donor2	11579-120F4	54.38	53.27	18.86	11.41	10.31	7.73	1.38	1.20	1.29
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	2.55	0.00	0.00	0.00	0.32	0.00	0.00	0.00	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	1.96	0.00	0.00	0.00	0.49	0.00	0.00	0.24	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	2.20	0.26	0.39	0.13	0.26	0.26	0.00	0.00	0.00
Placental Epithelial Cells, donor1	11278-116H9	3.83	6.22	0.96	1.67	0.24	0.24	0.96	0.00	0.24
Placental Epithelial Cells, donor2	11355-117H5	26.61	13.31	1.11	3.33	2.22	1.11	0.00	1.11	1.11
Placental Epithelial Cells, donor3	11427-118G5	10.60	9.62	4.12	3.14	2.94	0.79	0.39	0.20	0.20
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	6.33	7.59	0.63	1.90	0.95	0.00	0.63	0.00	0.00
Preadipocyte - breast, donor1	11467-119B9	16.32	15.76	1.69	3.38	2.63	1.69	0.94	0.56	0.38
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	10.44	9.40	3.39	4.31	2.09	1.70	0.91	0.26	1.31
Preadipocyte - breast, donor2	11328-117E5	6.98	12.38	3.15	4.73	1.13	1.80	1.35	0.00	0.23
Preadipocyte - omental, donor1	11468-119C1	31.22	26.43	6.50	6.39	2.56	3.94	0.85	3.20	0.96
Preadipocyte - omental, donor2	11329-117E6	38.41	27.06	9.60	6.98	3.49	8.29	0.44	1.75	0.87
Preadipocyte - omental, donor3	11403-118D8	22.63	20.20	5.73	3.72	3.29	4.58	1.29	0.86	0.29
Preadipocyte - perirenal, donor1	11469-119C2	31.50	11.81	7.87	5.91	0.98	4.92	0.00	1.97	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	10.13	15.66	1.23	5.22	1.84	1.23	1.23	0.61	1.54
Preadipocyte - subcutaneous, donor2	11356-117H6	18.59	25.85	4.78	6.91	3.90	2.48	1.42	0.00	1.24
Preadipocyte - subcutaneous, donor3	11428-118G6	15.33	19.75	3.75	4.77	1.87	2.72	0.51	0.00	0.34
Preadipocyte - visceral, donor1	11280-116I2	20.21	23.47	3.63	7.82	3.17	2.05	2.05	0.19	0.84
Preadipocyte - visceral, donor2	11357-117H7	23.47	22.55	8.28	5.98	3.68	0.92	1.84	0.46	0.00
Preadipocyte - visceral, donor3	11429-118G7	14.21	14.32	2.19	4.49	1.78	3.34	0.63	0.52	0.84
Prostate Epithelial Cells (polarized), donor1	11253-116F2	14.78	21.87	3.62	9.05	1.81	0.75	0.15	0.60	0.30
Prostate Epithelial Cells, donor2	11331-117E8	2.71	5.28	0.68	1.35	0.00	0.27	0.27	0.00	0.00
Prostate Epithelial Cells, donor3	11404-118D9	1.35	2.20	0.31	0.24	0.31	0.06	0.00	0.00	0.12
Prostate Stromal Cells, donor1	11254-116F3	77.22	70.28	15.38	14.92	9.57	14.24	0.80	5.58	0.57
Prostate Stromal Cells, donor2	11332-117E9	54.33	50.20	12.37	12.73	7.71	9.86	1.43	2.87	0.54
Prostate Stromal Cells, donor3	11405-118E1	62.46	47.34	19.71	11.05	9.18	13.14	1.25	5.01	0.63
Renal Cortical Epithelial Cells, donor1	11516-119H4	7.66	9.49	2.19	2.92	0.36	0.36	0.00	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	10.60	12.34	1.66	3.74	2.01	0.21	0.83	0.07	0.49
Renal Epithelial Cells, donor1	11517-119H5	7.10	4.57	1.52	1.01	0.00	0.00	1.01	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	4.27	4.98	1.42	2.13	0.71	0.00	0.00	0.00	0.71
Renal Epithelial Cells, donor3	11678-122H4	12.39	13.76	2.22	2.96	1.91	0.42	1.16	0.00	0.64
Renal Glomerular Endothelial Cells, donor1	11514-119H2	2.04	3.40	0.68	1.36	0.68	0.68	0.00	0.00	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	5.26	9.84	2.16	2.16	1.21	0.67	0.13	0.13	0.13
Renal Glomerular Endothelial Cells, donor3	11675-122H1	13.10	14.43	2.66	6.22	2.22	1.11	1.55	0.44	0.67
Renal Glomerular Endothelial Cells, donor4	11783-124B1	0.67	3.99	0.00	0.67	0.00	0.67	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	9.24	7.70	2.20	1.32	2.20	1.32	0.44	0.00	0.44
Renal Mesangial Cells, donor2	11598-120H5	7.52	5.02	2.51	1.25	1.88	0.00	0.63	0.00	0.63
Renal Mesangial Cells, donor3	11679-122H5	3.61	3.88	1.11	1.39	0.83	0.28	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	9.93	13.69	1.61	1.61	1.34	0.54	0.81	0.00	0.54
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	5.48	7.17	1.27	2.11	0.84	0.42	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	7.52	9.64	0.96	1.16	1.16	0.96	0.39	0.00	0.39
Retinal Pigment Epithelial Cells, donor0	11215-116A9	16.33	31.63	5.19	4.41	3.37	2.07	0.00	0.52	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	27.57	33.54	4.55	4.26	2.27	3.13	0.85	0.85	0.57
Retinal Pigment Epithelial Cells, donor2	11608-120I6	7.20	12.35	2.06	4.12	0.00	2.06	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	26.85	28.10	2.26	7.03	9.53	2.01	0.75	0.50	1.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	75.91	63.08	13.50	11.76	4.28	6.01	1.34	1.20	0.13
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	15.19	5.36	1.79	1.79	2.68	2.68	5.36	4.47	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	15.41	3.30	1.65	9.36	0.55	1.65	3.30	0.55	2.20
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	27.84	1.74	1.16	2.90	2.90	5.22	4.64	0.58	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	24.96	8.32	3.64	3.12	3.12	2.86	4.03	3.12	2.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	15.79	10.72	3.08	3.87	2.98	2.78	3.38	2.78	1.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	22.75	12.49	4.24	5.02	4.24	4.57	4.24	3.01	2.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	25.43	12.78	8.68	5.21	4.47	4.96	3.85	2.48	1.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	17.71	10.37	3.15	4.31	3.26	3.96	2.91	2.56	2.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	21.03	12.71	3.00	5.32	2.31	4.16	4.16	2.54	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	23.27	8.08	4.79	2.74	3.70	2.33	3.29	3.15	1.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	18.30	9.38	4.08	4.24	2.12	3.18	4.08	2.42	1.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	25.98	12.54	3.40	4.30	4.66	6.81	5.73	3.23	2.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	25.25	10.47	5.31	3.44	3.16	3.87	3.01	1.72	2.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	17.49	10.19	3.43	5.58	2.25	3.43	2.58	3.00	1.93
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	15.71	10.84	3.98	3.54	2.66	2.43	3.32	2.21	2.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	27.72	9.94	4.97	2.49	1.91	3.82	5.35	0.57	1.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	17.89	10.06	4.19	3.54	2.89	4.75	4.10	2.89	1.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	27.43	14.28	3.19	6.01	4.32	4.51	4.51	2.63	2.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	26.28	9.42	5.84	2.12	3.05	3.85	4.51	1.33	1.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	18.11	9.44	3.80	5.16	3.50	4.09	4.28	2.82	2.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	15.47	7.26	2.86	3.63	3.06	4.01	4.01	2.67	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	25.74	8.22	6.09	2.78	3.20	3.84	3.52	2.46	2.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	19.62	9.25	3.36	1.68	3.64	3.36	3.92	1.68	1.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	22.39	8.89	4.79	5.13	2.39	3.93	5.13	3.42	1.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	19.87	9.48	4.38	3.46	3.83	4.38	2.55	3.28	1.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	16.92	9.44	2.82	3.31	3.07	2.58	3.19	1.72	1.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	17.46	9.13	3.63	3.76	2.42	2.69	2.82	4.03	1.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	22.17	8.96	3.07	3.54	3.30	3.07	2.83	4.01	1.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	18.06	8.13	4.17	4.96	1.98	2.38	2.78	4.17	0.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	18.47	8.42	4.68	5.38	3.27	4.91	4.68	1.64	1.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	20.74	7.88	5.39	2.70	2.49	3.11	3.11	2.70	1.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	19.69	8.63	1.77	4.87	3.98	3.98	3.10	2.88	1.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	12.32	9.40	2.72	4.39	2.92	2.92	3.13	1.88	2.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	21.26	7.40	4.04	2.83	2.96	3.23	3.77	2.15	2.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	17.88	8.00	4.26	2.21	2.55	6.64	4.09	3.41	1.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	15.23	8.68	3.47	5.40	4.24	4.43	6.17	4.63	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	25.96	9.63	5.16	3.27	3.95	4.99	4.30	3.44	2.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	20.30	9.05	3.02	3.43	3.02	3.43	4.25	2.47	1.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	18.22	7.88	3.28	3.78	4.27	5.25	4.43	3.12	1.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	33.92	10.74	6.65	3.41	3.58	5.62	4.26	3.41	2.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	24.71	13.76	5.62	4.29	4.14	5.18	3.26	2.07	2.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	22.66	8.00	5.86	4.53	2.40	4.53	5.60	1.87	1.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	36.92	10.23	7.19	4.29	5.39	5.81	3.18	4.56	3.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	20.95	9.76	3.10	3.81	3.81	5.24	2.38	3.81	1.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	26.00	8.87	6.45	4.43	4.03	3.63	4.23	4.23	1.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	19.12	7.72	5.18	3.67	3.58	3.01	3.20	2.17	2.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	27.60	13.97	3.84	1.40	3.14	4.54	4.19	3.49	1.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	18.74	6.35	6.65	4.84	3.93	6.35	3.93	4.23	2.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	22.89	6.61	6.24	5.39	2.45	4.41	3.79	2.33	1.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	51.09	17.61	10.92	9.46	8.44	8.88	9.75	9.75	3.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	27.99	7.91	7.91	5.48	3.65	3.65	4.26	4.87	1.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	27.13	5.73	4.52	5.12	2.11	3.92	2.71	4.22	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	23.98	13.57	4.30	7.24	3.39	3.62	6.11	3.85	1.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	25.76	7.49	5.69	6.89	3.59	3.59	4.79	2.40	2.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	42.27	9.09	7.08	6.73	5.79	6.49	4.37	6.02	2.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	23.27	9.18	7.26	7.47	3.20	5.34	4.70	3.42	1.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	30.05	7.21	8.41	6.01	3.00	3.61	4.81	6.01	3.00
Schwann Cells, donor1	11498-119F4	5.27	4.33	1.13	2.07	1.32	0.38	0.19	0.38	0.00
Schwann Cells, donor2	11578-120F3	20.41	3.40	3.40	0.00	3.40	0.00	3.40	0.00	0.00
Schwann Cells, donor3	11659-122F3	13.14	19.94	3.72	6.13	3.94	1.31	0.22	0.66	0.44
Sebocyte, donor1	11220-116B5	3.29	1.64	0.00	0.00	0.00	0.00	0.55	0.00	0.00
Sebocyte, donor2	11301-117B5	1.84	1.38	0.00	0.00	0.92	0.00	0.00	0.00	0.00
Sebocyte, donor3	11378-118B1	3.71	4.74	2.27	0.82	0.41	1.03	0.00	0.00	0.21
Sertoli Cells, donor1	11255-116F4	53.01	64.61	14.91	23.19	3.31	1.66	1.66	1.66	0.00
Sertoli Cells, donor2	11333-117F1	19.77	8.47	2.82	14.12	2.82	2.82	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	15.57	15.92	3.78	6.51	3.34	4.66	0.62	3.96	0.62
Skeletal Muscle Cells, donor2	11358-117H8	8.67	7.95	2.89	2.17	0.72	1.45	0.00	2.89	0.72
Skeletal Muscle Cells, donor3	11430-118G8	12.54	14.21	2.51	10.87	2.51	4.18	0.00	0.84	0.00
Skeletal Muscle Cells, donor4	11451-119A2	12.41	15.40	2.51	2.83	3.30	1.10	0.79	0.47	0.63
Skeletal Muscle Cells, donor5	11455-119A6	15.01	20.81	4.91	4.16	2.53	1.78	0.45	1.19	0.30
Skeletal Muscle Cells, donor6	11459-119B1	13.70	14.01	3.69	4.31	3.69	2.00	0.92	1.39	0.77
Skeletal Muscle Satellite Cells, donor1	11240-116D7	22.05	25.71	4.79	6.17	5.42	1.76	0.63	0.25	0.76
Skeletal Muscle Satellite Cells, donor2	11321-117D7	17.27	25.54	3.14	7.56	4.14	2.00	0.57	0.86	0.29
Skeletal Muscle Satellite Cells, donor3	11397-118D2	11.51	14.78	4.07	3.97	3.17	2.08	1.19	0.99	1.29
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	14.07	30.16	3.37	8.85	2.44	4.72	0.67	2.86	0.25
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	11.58	5.79	3.62	1.45	1.45	2.90	0.00	1.45	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	6.88	7.71	1.65	3.16	1.79	1.79	0.41	1.10	0.55
Skin - palm, donor1	10286-104F7	2.69	5.37	0.00	0.00	0.00	0.00	2.69	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	1.15	2.02	0.00	1.59	0.29	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	5.73	9.81	0.82	5.73	0.82	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	2.34	2.60	0.26	1.43	0.13	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	1.53	2.78	0.14	1.81	1.11	0.14	0.14	0.00	0.00
Small Airway Epithelial Cells, donor2	11334-117F2	3.52	4.36	0.70	1.55	0.70	0.14	0.14	0.00	0.00
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	9.52	14.80	2.33	6.34	1.69	0.63	1.06	0.00	0.63
Small Airway Epithelial Cells, donor3	11406-118E2	2.17	4.27	0.37	0.67	0.82	0.15	0.07	0.00	0.22
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	38.88	20.68	6.79	4.32	3.09	3.70	0.00	0.62	0.62
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	40.46	18.90	6.23	7.78	3.56	4.45	1.11	1.11	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	17.63	22.93	2.35	0.00	2.94	2.94	1.76	0.59	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	16.57	21.22	5.75	9.94	3.31	3.76	0.22	0.66	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	12.60	5.51	2.36	3.94	1.58	2.36	0.39	0.00	1.18
Smooth Muscle Cells - Aortic, donor3	11432-118H1	27.04	12.36	5.41	4.64	5.41	2.32	2.32	0.77	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	37.03	33.02	11.01	8.01	5.00	6.00	1.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	19.70	17.17	3.99	5.32	2.53	3.19	0.40	1.33	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	7.31	5.32	2.88	2.22	1.55	0.00	0.44	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	14.72	15.62	2.94	3.71	1.54	0.90	0.90	0.38	0.38
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	15.30	7.16	5.54	2.28	5.54	4.88	1.63	1.30	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	32.49	25.99	10.93	5.02	7.38	5.32	0.00	0.89	1.77
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	51.11	38.01	13.81	9.82	6.12	7.40	1.14	3.13	0.57
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	13.01	6.18	1.79	0.81	0.81	0.98	0.33	0.33	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	30.14	24.35	6.39	8.22	5.48	5.78	1.52	1.22	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	6.31	4.80	1.52	4.80	1.26	0.00	0.51	0.00	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	0.00	0.00	0.00	0.00	6.12	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	9.06	5.72	1.43	3.81	0.48	1.91	0.48	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	40.70	29.05	8.55	7.67	4.42	8.11	0.29	2.06	0.59
Smooth Muscle Cells - Colonic, donor2	11320-117D6	38.96	33.15	9.26	9.26	3.87	6.67	0.86	2.37	0.86
Smooth Muscle Cells - Colonic, donor3	11396-118D1	27.92	31.49	8.61	7.45	4.20	6.51	0.84	2.10	0.21
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	9.44	5.88	1.39	1.39	1.55	1.86	0.77	0.62	0.15
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	21.56	11.86	1.08	4.31	0.00	3.23	0.00	1.08	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	24.21	21.52	7.47	6.87	2.99	5.08	2.09	0.30	0.60
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	28.34	24.58	4.10	5.80	2.39	4.44	0.68	1.71	1.02
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	102.72	98.40	20.89	19.79	12.17	14.45	0.47	2.83	0.47
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	6.84	8.66	0.70	3.02	1.21	0.81	0.60	0.10	0.30
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	17.98	11.15	4.10	4.32	2.50	1.82	0.91	0.23	0.23
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	14.49	16.91	3.62	5.43	1.81	2.42	0.60	1.21	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	44.24	53.25	16.96	11.13	6.89	9.27	0.26	0.26	0.79
Smooth Muscle Cells - Prostate, donor1	11257-116F6	65.78	42.74	14.11	8.26	5.99	8.66	1.20	1.73	0.27
Smooth Muscle Cells - Prostate, donor2	11335-117F3	87.53	75.01	22.16	14.02	10.52	16.03	1.38	5.01	0.88
Smooth Muscle Cells - Prostate, donor3	11465-119B7	15.73	7.36	4.57	3.04	3.04	4.06	0.76	1.01	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	12.97	13.27	3.02	2.11	1.51	2.86	0.75	0.15	0.15
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	8.25	3.75	0.75	0.00	0.00	0.00	0.00	0.75	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	0.00	2.58	0.00	43.94	1.29	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	20.93	21.86	4.65	6.05	1.86	0.47	0.47	0.47	0.93
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	14.14	11.61	2.02	1.51	1.51	0.50	0.00	0.50	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	8.46	7.83	3.45	3.76	1.57	0.94	0.00	0.63	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	11.50	7.08	2.06	0.88	0.88	0.88	0.00	0.88	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	26.32	24.41	8.16	4.58	4.58	3.58	0.67	0.83	1.25
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	34.10	35.04	11.68	7.47	3.74	4.67	1.40	1.40	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	30.94	17.27	6.91	6.48	3.31	6.04	0.72	1.87	1.15
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	13.26	10.96	5.61	4.84	2.04	2.80	0.25	0.25	0.76
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	10.72	15.23	3.76	4.32	2.07	1.32	0.56	1.13	0.19
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	31.58	30.88	8.94	7.27	5.87	4.19	0.84	1.40	0.98
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	29.07	29.49	10.39	9.38	4.44	2.77	0.92	1.01	0.67
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	6.19	2.86	0.00	1.43	0.48	0.48	0.48	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	24.47	17.62	8.32	6.36	2.45	5.63	0.73	1.47	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	91.47	27.62	19.00	7.51	5.30	14.58	2.21	6.85	1.33
Smooth Muscle Cells - Uterine, donor3	11466-119B8	11.70	6.73	3.80	2.63	1.76	1.76	0.00	1.46	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	47.42	43.54	8.55	10.30	3.50	10.11	0.97	1.55	0.78
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	16.93	13.22	1.59	5.29	2.38	3.70	0.26	0.79	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	17.48	8.93	1.49	7.44	1.86	4.84	0.37	0.74	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	82.29	34.50	11.14	8.26	5.75	14.01	1.08	3.95	1.08
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	13.06	9.94	1.70	1.70	1.42	4.54	0.85	0.57	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	13.39	10.63	0.79	3.15	0.79	1.18	0.00	0.00	1.18
Smooth muscle cells - airway, control, donor1	11966-126D4	22.35	21.84	2.79	6.60	1.27	3.30	0.51	0.76	0.25
Smooth muscle cells - airway, control, donor2	11967-126D5	39.53	24.76	6.79	10.38	2.80	3.59	0.00	0.40	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	20.48	18.81	2.51	7.52	0.84	6.27	0.42	0.84	0.84
Smooth muscle cells - airway, control, donor4	11969-126D7	27.04	26.13	4.58	9.63	3.21	3.21	0.00	0.92	0.46
Synoviocyte, donor1	11291-117A4	7.74	8.58	1.85	2.69	1.01	0.67	0.67	0.00	0.17
Synoviocyte, donor2	11368-117I9	4.36	5.36	1.68	1.84	1.68	1.01	0.00	0.00	0.00
Synoviocyte, donor3	11440-118H9	4.47	4.47	1.12	2.01	0.45	0.45	0.00	0.22	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	18.22	13.94	2.86	3.57	2.86	1.79	1.07	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	7.93	11.89	1.98	5.95	0.00	0.00	0.00	0.00	1.98
Trabecular Meshwork Cells, donor3	11693-123A1	20.84	25.93	4.40	3.01	3.24	3.70	0.23	0.46	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	1.43	1.08	0.14	0.22	0.22	0.00	0.07	0.00	0.07
Tracheal Epithelial Cells, donor2	11369-118A1	1.93	2.71	0.00	1.16	0.00	0.00	0.00	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	0.57	0.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	78.86	65.45	12.30	9.10	5.17	7.38	1.11	0.98	0.37
Urethra, donor2	10319-105A4	8.99	12.59	1.80	1.80	0.00	1.80	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	2.66	4.25	0.27	0.27	0.27	0.00	0.00	0.00	0.00
Urothelial Cells, donor2	11600-120H7	1.60	1.60	0.00	0.80	0.00	0.00	0.00	0.00	0.00
Urothelial Cells, donor3	11681-122H7	0.69	4.81	0.23	0.46	0.00	0.00	0.00	0.00	0.00
Urothelial cells, donor0	11216-116B1	7.80	16.49	0.67	3.12	0.89	0.45	0.45	0.00	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	7.12	0.00	0.89	0.00	0.00	1.78	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	7.15	1.43	1.43	0.00	1.43	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	2.74	0.00	0.68	0.00	0.68	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	2.07	0.34	0.69	0.00	0.69	0.00	0.34	0.34	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	2.32	0.58	1.16	0.00	0.58	0.58	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	1.04	1.04	1.04	0.00	2.08	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	3.67	0.92	0.92	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	2.74	0.91	0.00	0.00	0.91	0.00	0.00	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	3.58	1.23	0.62	0.37	0.12	0.37	0.00	0.00	0.00
Wilms' tumor cell line:HFWT	10597-108E3	4.40	0.88	0.88	0.00	0.00	0.88	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	23.18	55.58	5.59	9.50	3.91	1.96	1.12	0.84	0.00
achilles tendon, donor2	10292-104G4	2.07	8.27	2.07	0.00	0.00	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	3.57	1.78	0.25	0.25	1.27	0.00	0.25	0.00	0.76
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	8.82	1.63	0.23	0.70	2.32	0.23	1.16	0.00	0.23
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	14.60	0.36	1.07	0.00	3.32	0.12	0.12	0.00	0.24
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	9.25	0.54	1.09	0.54	2.99	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	0.85	0.21	0.00	0.00	0.00	0.00	0.21	0.00	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	28.31	40.83	1.91	7.35	7.08	1.36	3.54	0.54	0.54
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	3.53	2.64	0.88	0.88	2.20	0.00	0.88	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	13.07	2.04	0.00	0.00	0.82	0.00	0.41	0.00	0.41
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	21.36	1.94	1.94	1.16	3.88	0.78	3.11	1.16	1.16
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	2.21	0.92	0.37	0.74	0.55	0.00	0.92	0.00	0.18
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	23.40	3.90	0.00	3.90	7.80	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	3.02	0.23	0.23	0.46	0.46	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	1.81	0.00	0.00	0.52	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	1.17	0.29	0.00	0.29	0.29	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	1.39	0.00	0.00	0.00	0.46	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	16.04	3.29	0.00	2.06	0.41	0.82	2.06	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	0.31	0.00	0.00	0.00	0.31	0.00	0.31	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	0.85	0.43	0.85	0.00	0.00	0.43	1.28	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	1.52	0.61	0.30	0.30	0.91	0.00	1.52	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	0.72	0.00	0.24	0.48	0.24	0.00	0.00	0.48	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	11.67	13.01	2.33	3.34	3.00	2.67	2.00	0.67	1.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	33.45	1.86	0.00	1.86	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	12.81	12.43	1.13	5.65	1.51	1.51	0.00	0.00	1.13
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	11.78	11.78	1.74	1.31	1.31	1.31	4.36	0.87	0.87
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	11.25	18.74	3.75	0.00	7.50	1.87	0.00	0.00	3.75
adenocarcinoma cell line:IM95m	10796-110I4	1.41	2.35	0.24	0.24	1.18	0.00	0.00	0.00	0.00
adipose tissue, adult, pool1	10010-101C1	23.73	31.64	6.83	5.12	1.71	3.10	0.47	1.09	0.47
adipose, donor1	10184-103D4	0.59	0.59	0.59	0.00	0.00	0.00	0.00	0.00	0.00
adipose, donor2	10185-103D5	6.89	3.65	0.81	2.03	2.03	1.22	0.00	0.00	0.00
adipose, donor3	10186-103D6	5.17	5.72	1.09	2.45	1.36	0.54	0.54	0.00	0.00
adipose, donor4	10187-103D7	1.73	1.73	0.87	6.93	1.73	0.00	0.00	0.00	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	4.89	1.42	0.32	0.32	3.31	0.00	0.47	0.00	0.63
adrenal gland, adult, pool1	10081-102A9	25.46	10.91	0.00	7.28	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	32.87	24.65	6.79	6.43	4.64	6.07	0.00	0.71	0.00
amniotic membrane cells, donor1	12235-129G3	10.20	12.98	4.64	2.78	1.62	0.93	0.46	0.00	0.00
amniotic membrane cells, donor2	12236-129G4	110.90	79.79	57.14	26.03	10.48	12.85	0.34	1.35	0.00
amniotic membrane cells, donor3	12237-129G5	15.32	15.32	3.83	1.47	1.18	0.29	0.00	0.00	0.00
amygdala - adult, donor10196	10167-103B5	35.57	17.79	4.74	1.19	4.74	8.30	0.00	0.00	0.00
amygdala, adult, donor10252	10151-102I7	49.48	45.42	17.64	11.35	6.29	5.27	0.61	1.82	0.00
amygdala, newborn, donor10223	10360-105E9	11.62	12.91	1.61	2.58	2.58	1.29	1.29	0.32	0.32
anaplastic carcinoma cell line:8305C	10428-106D5	26.36	32.60	1.66	7.64	3.18	1.02	0.89	1.02	0.64
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	0.00	0.00	0.00	0.00	0.22	0.00	0.00	0.00	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	5.01	4.01	0.00	0.67	4.34	0.00	0.00	0.00	0.00
aorta, adult, pool1	10052-101G7	5.88	7.26	2.94	1.18	1.18	0.98	0.00	0.20	0.00
appendix, adult	10189-103D9	11.64	18.24	2.72	1.55	0.78	3.10	0.00	0.78	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	11.69	11.69	1.38	3.10	1.38	1.03	0.34	0.00	0.69
artery, adult	10190-103E1	13.59	20.38	0.00	5.43	1.36	1.36	0.00	1.36	0.00
astrocytoma cell line:TM-31	10425-106D2	24.19	8.55	4.64	1.45	4.49	1.01	4.78	0.58	1.74
b cell line:RPMI1788	10427-106D4	11.45	2.38	1.78	0.30	2.83	0.45	0.89	0.00	0.30
basal cell carcinoma cell line:TE 354.T	10702-109G9	9.71	4.72	2.50	2.22	1.11	0.83	0.55	0.28	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	22.23	20.14	3.18	5.16	1.69	1.59	1.49	0.30	1.09
bile duct carcinoma cell line:TFK-1	10496-107C1	2.34	2.68	0.84	0.50	0.33	0.00	0.17	0.17	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	2.24	0.56	0.00	0.00	0.00	0.00	1.12	0.00	0.00
bladder, adult, pool1	10011-101C2	16.62	14.12	5.00	3.15	2.28	0.87	0.22	0.33	0.22
blood, adult, pool1	10053-101G8	0.00	0.00	2.21	0.00	0.00	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	6.85	4.28	3.43	0.00	0.00	0.86	0.00	0.00	0.00
bone marrow, adult	10192-103E3	37.79	33.74	5.40	8.10	5.40	6.75	2.02	6.07	2.02
brain, adult, donor1	10084-102B3	25.63	19.48	4.10	2.05	8.20	4.10	0.00	0.00	0.00
brain, adult, pool1	10012-101C3	54.68	27.84	14.37	5.46	7.35	7.57	0.78	1.45	0.00
brain, fetal, pool1	10085-102B4	0.00	8.01	2.67	0.00	0.00	2.67	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	70.04	91.51	22.80	4.29	4.63	12.55	2.64	5.62	0.99
breast carcinoma cell line:MDA-MB-453	10419-106C5	0.00	0.00	0.00	0.00	0.12	0.00	0.00	0.00	0.00
breast, adult, donor1	10080-102A8	10.73	16.42	6.31	1.26	0.00	1.26	1.26	1.26	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	29.73	30.62	8.00	5.59	3.94	2.92	2.41	1.27	0.25
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	13.30	11.75	2.47	1.86	1.55	1.24	3.40	1.24	0.93
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	3.22	1.61	0.69	2.30	0.92	0.00	0.00	0.00	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	34.13	51.81	7.26	6.05	4.84	5.08	0.24	1.21	0.24
carcinoid cell line:NCI-H1770	10703-109H1	1.41	29.15	1.41	2.82	0.47	0.94	1.41	0.00	1.41
carcinoid cell line:NCI-H727	10735-110B6	8.75	5.47	1.97	1.31	0.33	0.66	1.42	0.55	0.66
carcinoid cell line:SK-PN-DW	10719-109I8	10.14	11.09	1.90	0.95	0.95	0.63	0.32	0.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	10.38	5.32	0.53	1.06	1.60	0.27	0.80	0.00	0.27
caudate nucleus - adult, donor10196	10177-103C6	33.39	26.48	9.21	9.21	4.61	4.61	2.30	2.30	0.00
caudate nucleus, adult, donor10252	10164-103B2	49.36	34.80	18.24	7.03	8.20	6.19	0.17	2.18	0.33
caudate nucleus, adult, donor10258	10379-105H1	34.39	22.92	6.11	3.06	6.11	3.82	0.76	2.29	0.00
caudate nucleus, newborn, donor10223	10354-105E3	17.21	13.92	2.56	5.13	2.56	3.30	1.10	0.73	1.10
cerebellum - adult, donor10196	10173-103C2	43.70	8.74	0.00	0.00	0.00	2.91	2.91	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	36.72	33.73	16.01	6.41	5.12	4.27	1.28	0.85	0.21
cerebellum, adult, pool1	10083-102B2	7.24	6.21	4.48	1.38	1.03	1.03	0.34	0.34	0.34
cerebellum, newborn, donor10223	10357-105E6	18.27	18.27	1.66	4.15	0.00	0.83	2.49	0.00	2.49
cerebral meninges, adult	10188-103D8	26.22	15.63	8.32	1.01	3.03	5.04	0.76	0.50	0.00
cerebrospinal fluid, donor2	10294-104G6	5.85	9.50	0.73	0.73	0.00	0.73	0.00	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	17.11	24.59	4.46	2.73	1.87	1.44	2.88	0.29	0.86
cervical cancer cell line:ME-180	10553-107I4	38.78	74.08	8.12	10.27	4.64	3.31	2.32	0.33	0.83
cervix, adult, pool1	10013-101C4	21.00	17.53	4.62	4.30	3.25	1.26	0.52	0.31	0.10
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	109.52	102.97	31.35	10.59	11.15	22.85	0.84	11.43	1.25
chondrosarcoma cell line:SW 1353	10700-109G7	7.84	15.68	1.31	2.61	1.31	3.92	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
choriocarcinoma cell line:SCH	10785-110H2	9.61	5.91	1.72	2.22	0.99	0.74	0.86	0.00	0.37
choriocarcinoma cell line:T3M-3	10618-108G6	2.61	0.00	1.19	0.95	0.95	0.00	0.95	0.00	0.47
chorionic membrane cells, donor1	12238-129G6	9.40	6.27	3.13	4.27	1.14	0.57	0.57	0.00	0.00
chorionic membrane cells, donor2	12239-129G7	47.83	37.09	20.68	5.87	5.17	5.47	2.29	1.09	0.40
chorionic membrane cells, donor3	12240-129G8	10.99	3.85	6.04	2.75	0.55	0.55	1.10	0.00	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	5.05	1.01	0.00	1.01	0.00	1.01	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	8.45	4.61	1.15	1.73	0.58	0.19	1.73	0.19	1.54
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	6.76	4.01	2.32	0.63	1.06	1.06	3.59	0.42	1.69
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	29.79	35.18	9.76	12.58	3.08	3.60	2.05	0.77	0.77
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	34.35	33.38	12.58	10.88	4.11	3.63	1.21	0.48	0.48
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	35.63	37.26	10.18	12.42	4.48	3.66	1.02	0.81	1.43
chronic myelogenous leukemia cell line:K562	10454-106G4	35.92	38.28	12.07	7.36	8.24	4.42	1.77	1.77	0.29
chronic myelogenous leukemia cell line:KU812	10409-106B4	25.02	15.90	6.26	1.56	3.13	2.09	1.04	0.52	1.04
clear cell carcinoma cell line:JHOC-5	10638-108I8	4.57	0.69	0.91	0.00	0.91	0.00	0.23	0.00	0.23
clear cell carcinoma cell line:TEN	10636-108I6	42.68	25.16	10.58	10.58	3.99	4.68	1.91	0.52	0.69
colon carcinoma cell line:CACO-2	10513-107D9	12.08	10.25	2.38	4.21	1.10	0.37	1.65	0.00	1.46
colon carcinoma cell line:COLO-320	10420-106C6	36.87	97.68	5.70	6.08	3.04	2.28	0.38	0.76	0.38
colon, adult, donor1	10082-102B1	16.66	20.23	5.95	1.19	1.19	1.19	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	19.74	31.73	4.94	3.29	2.12	1.41	0.47	0.71	1.06
colon, fetal, donor1	10070-101I7	14.83	22.25	5.56	2.47	2.47	2.47	0.62	0.00	0.00
common myeloid progenitor CMP, donor1	12130-128D6	100.84	18.33	13.75	4.58	18.33	4.58	0.00	4.58	0.00
common myeloid progenitor CMP, donor2	12134-128E1	50.07	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a untreated	10449-106F8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
corpus callosum, adult, pool1	10042-101F6	73.52	60.59	16.14	9.29	7.63	8.73	1.99	2.54	0.33
cruciate ligament, donor2	10295-104G7	8.92	10.54	3.24	0.81	0.81	1.62	3.24	0.81	0.00
diaphragm, fetal, donor1	10069-101I6	16.85	20.87	10.43	2.41	0.80	0.80	0.00	0.00	0.00
diencephalon, adult	10193-103E4	36.72	24.24	10.08	4.08	5.52	4.32	1.44	0.72	0.24
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	0.46	0.23	0.00	0.00	0.23	0.00	0.00	0.00	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	4.36	6.15	0.00	1.03	0.77	0.00	2.31	0.00	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	2.17	2.65	0.72	0.48	0.48	0.00	0.00	0.00	0.00
ductus deferens, adult	10196-103E7	19.44	29.40	3.49	3.99	0.00	3.49	0.00	1.99	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	14.40	15.84	7.20	1.44	1.44	0.00	0.00	1.44	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	24.28	34.58	8.09	4.41	0.74	2.94	0.74	0.74	0.00
dura mater, adult, donor1	10041-101F5	24.36	23.79	5.53	4.29	4.05	3.06	1.73	0.66	0.74
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	6.00	10.22	1.55	4.22	1.11	0.67	0.89	0.22	0.67
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	8.60	16.34	2.29	2.58	1.29	1.43	0.86	0.29	0.14
embryonic pancreas cell line:1B2C6	10604-108F1	6.78	0.62	0.00	0.00	0.00	0.00	0.00	0.00	0.62
embryonic pancreas cell line:1C3D3	10605-108F2	8.48	2.42	0.61	0.91	2.12	0.30	0.30	0.00	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	13.28	1.54	1.54	0.31	1.54	0.31	0.31	0.31	0.00
embryonic pancreas cell line:2C6	10603-108E9	5.25	1.31	3.94	0.00	1.31	0.00	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	26.82	10.06	4.36	4.02	1.68	3.02	2.35	0.34	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
epidermoid carcinoma cell line:A431	10426-106D3	7.45	11.00	1.00	2.11	1.11	0.33	1.33	0.11	0.44
epidermoid carcinoma cell line:Ca Ski	10431-106D8	19.91	29.92	3.96	6.05	1.76	0.77	0.88	0.55	0.22
epididymis, adult	10197-103E8	19.68	27.63	4.81	4.19	1.88	2.51	1.26	1.05	0.63
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	1.42	0.53	0.18	0.18	0.53	0.18	0.18	0.00	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	21.23	60.15	6.55	8.13	4.59	1.97	3.01	0.79	1.97
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	31.30	106.69	10.24	10.73	5.02	3.54	5.61	1.18	1.87
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	21.62	57.47	5.04	7.62	3.92	2.13	3.70	0.56	1.12
esophagus, adult, pool1	10015-101C6	7.64	11.47	2.02	1.49	1.06	0.53	0.32	0.32	0.00
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
eye - muscle inferior rectus, donor1	10272-104E2	33.80	12.07	0.00	2.41	0.00	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	2.10	14.73	0.00	2.10	2.10	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	11.91	14.88	1.49	0.00	0.00	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	10.32	13.76	5.73	2.29	0.00	3.44	1.15	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	14.57	17.49	0.00	0.00	1.46	1.46	0.00	1.46	0.00
eye, fetal, donor1	10054-101G9	17.29	15.25	7.63	3.56	3.56	0.76	1.78	0.25	1.02
fibrosarcoma cell line:HT-1080	10758-110E2	9.36	4.87	2.56	2.95	1.54	0.51	1.28	0.38	0.64
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	34.66	18.99	5.46	4.51	2.61	6.65	2.61	1.90	2.37
frontal lobe, adult, pool1	10040-101F4	41.85	23.17	9.95	2.81	6.47	4.41	0.56	2.06	0.19
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	24.62	47.44	6.00	8.11	4.20	1.80	2.10	0.60	0.60
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	47.18	29.35	12.25	10.88	4.39	7.22	0.73	2.56	0.18
gall bladder, adult	10198-103E9	8.69	12.80	2.66	1.45	0.72	1.93	0.72	0.72	0.00
gamma delta positive T cells, donor1	11937-126A2	4.83	0.00	0.54	0.00	1.07	0.00	0.00	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	16.06	1.87	0.75	0.00	2.24	1.49	2.24	0.00	0.75
gastric adenocarcinoma cell line:MKN1	10614-108G2	39.92	49.00	7.82	5.70	7.39	5.49	1.27	1.90	0.63
gastric adenocarcinoma cell line:MKN45	10612-108F9	0.19	0.39	0.00	0.00	0.39	0.00	0.00	0.00	0.00
gastric cancer cell line:AZ521	10549-107H9	15.58	1.97	1.15	1.31	3.12	0.66	1.31	0.33	0.16
gastric cancer cell line:GSS	10560-108A2	13.73	2.75	1.83	2.75	3.66	0.00	1.83	0.00	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	10.74	8.68	4.11	1.83	3.20	1.60	4.34	0.00	1.83
giant cell carcinoma cell line:LU65	10487-107B1	3.90	4.82	0.57	1.26	0.46	0.23	0.23	0.11	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	19.59	7.70	3.36	1.82	4.34	2.24	1.40	0.28	1.54
glassy cell carcinoma cell line:HOKUG	10688-109F4	5.24	28.43	1.50	4.24	1.00	0.75	2.00	0.25	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	16.26	18.68	3.27	2.85	2.43	3.48	4.12	0.53	0.95
glioblastoma cell line:A172, tech_rep2	10444-106F3	15.87	14.75	5.62	2.25	2.67	2.11	2.81	0.98	2.39
glioblastoma cell line:T98G	10485-107A8	64.79	55.96	22.07	5.74	7.17	13.36	1.10	4.97	0.88
glioma cell line:GI-1	10413-106B8	37.20	44.22	12.01	11.42	3.81	7.61	1.17	2.34	1.17
globus pallidus - adult, donor10196	10175-103C4	28.43	24.05	15.31	5.10	2.19	2.19	1.46	0.73	0.73
globus pallidus, adult, donor10252	10161-103A8	49.31	60.78	20.99	8.30	6.59	7.57	0.98	0.98	0.00
globus pallidus, adult, donor10258	10367-105F7	35.60	35.60	5.48	6.85	6.85	5.48	0.00	2.74	1.37
globus pallidus, newborn, donor10223	10364-105F4	20.78	24.51	4.26	6.40	2.66	5.33	1.07	1.07	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	88.10	4.89	4.89	2.45	9.79	4.89	4.89	4.89	2.45
granulocyte macrophage progenitor, donor2	12135-128E2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	5.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	14.40	19.20	6.40	5.44	0.96	4.16	0.32	0.64	0.32
hIPS +CCl2, biol_rep1	14383-156B9	5.97	2.30	1.84	0.92	0.92	0.00	0.46	0.00	0.00
hIPS +CCl2, biol_rep2	14384-156C1	8.23	1.37	0.91	1.37	0.91	0.91	0.00	0.00	0.00
hIPS +CCl2, biol_rep3	14385-156C2	9.02	0.00	1.29	1.93	1.29	0.00	0.64	0.00	0.00
hIPS, biol_rep1	14380-156B6	4.31	0.00	0.00	4.31	0.00	0.00	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	2.74	0.69	0.69	2.06	0.00	0.00	0.00	0.00	0.00
hIPS, biol_rep3	14382-156B8	37.52	12.14	12.14	3.31	5.52	0.00	0.00	1.10	0.00
hairy cell leukemia cell line:Mo	10712-109I1	5.75	2.01	1.15	0.86	2.30	0.57	0.29	0.00	0.86
heart - mitral valve, adult	10205-103F7	14.05	18.24	4.78	2.39	1.79	2.39	1.20	0.60	0.30
heart - pulmonic valve, adult	10206-103F8	17.52	20.92	4.45	1.83	1.57	1.31	0.52	0.52	0.26
heart - tricuspid valve, adult	10207-103F9	10.82	10.82	1.67	2.50	0.83	1.67	0.83	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	13.88	10.81	4.49	2.45	2.86	1.84	0.82	0.41	0.00
heart, adult, diseased, donor1	10051-101G6	9.79	8.09	5.54	0.85	2.55	1.70	0.00	1.28	0.43
heart, adult, pool1	10016-101C7	16.56	20.01	10.35	3.91	1.84	1.61	0.23	0.46	0.23
heart, fetal, pool1	10046-101G1	63.76	55.86	15.40	7.80	4.21	5.65	1.85	1.33	1.64
hepatic mesenchymal tumor cell line:LI90	10778-110G4	17.28	18.20	2.47	2.78	2.78	1.23	0.93	0.00	0.62
hepatoblastoma cell line:HuH-6	10633-108I3	7.14	4.76	0.00	0.00	2.38	0.00	0.00	0.00	1.19
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	7.29	9.06	2.98	4.86	1.88	0.88	2.32	0.22	1.22
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	8.98	9.83	2.31	3.28	2.43	0.97	1.70	0.12	0.97
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	9.60	10.41	3.13	4.65	1.72	0.91	2.12	0.10	0.91
hepatoma cell line:Li-7	10484-107A7	13.90	15.13	3.56	1.11	1.33	1.33	1.56	0.00	1.00
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	3.52	3.02	0.90	0.90	0.70	0.40	1.41	0.00	0.40
hippocampus - adult, donor10196	10169-103B7	37.85	23.66	8.52	3.79	3.79	9.46	0.00	0.95	0.00
hippocampus, adult, donor10252	10153-102I9	69.39	54.49	29.80	13.06	9.80	7.96	0.82	2.04	0.20
hippocampus, adult, donor10258	10374-105G5	40.33	12.95	2.49	2.99	3.98	4.98	0.50	1.00	0.00
hippocampus, newborn, donor10223	10363-105F3	11.63	12.34	2.47	4.93	2.11	3.17	1.06	0.35	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	6.71	0.00	1.22	0.00	0.00	0.61	1.83	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	5.50	2.36	1.96	2.95	0.20	0.20	0.39	0.20	0.20
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	4.57	2.29	0.25	1.78	0.76	1.27	0.25	0.25	0.25
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	1.13	0.56	0.00	0.00	0.00	0.56	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	2.58	0.52	0.26	0.26	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	3.42	0.76	0.00	0.00	0.76	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	4.67	2.34	0.00	0.88	0.58	0.29	0.00	0.00	0.29
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	4.31	3.66	0.65	1.72	1.72	0.00	0.00	0.22	0.43
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	5.42	7.09	0.42	2.09	0.00	0.42	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	11.37	18.47	1.66	4.03	2.60	2.13	1.66	0.47	0.95
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	8.84	18.00	2.73	3.86	2.41	0.96	1.13	0.16	0.96
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	8.75	20.20	2.02	3.37	2.02	2.69	0.67	1.35	1.35
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	2.66	1.41	0.47	1.41	0.31	0.31	0.16	0.16	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	1.97	0.00	0.00	1.47	0.49	0.00	0.49	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	0.87	0.00	0.00	1.75	0.00	0.87	0.87	0.00	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	1.53	0.57	0.19	0.38	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	1.31	2.18	0.87	0.44	0.44	0.00	0.44	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	2.00	0.00	0.00	1.50	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	3.20	3.39	0.57	2.07	1.70	0.38	0.38	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	2.73	4.09	0.45	4.09	0.45	0.45	0.45	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	2.51	3.45	0.63	2.82	1.88	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	6.70	6.70	1.31	4.57	1.80	0.49	0.49	0.33	0.33
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	8.42	6.39	0.00	3.48	0.58	0.87	0.58	0.29	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	3.29	10.46	1.49	3.59	1.79	0.60	1.49	0.30	0.60
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	5.36	2.40	0.92	2.40	1.29	0.74	0.37	0.00	0.18
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	4.85	2.28	1.43	2.00	1.14	0.86	0.29	0.29	0.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	6.12	2.45	1.22	1.63	1.22	0.82	1.63	0.00	0.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	2.82	1.41	0.35	1.06	0.00	0.00	0.70	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	2.53	1.90	1.27	1.90	1.27	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	3.63	0.61	0.00	0.61	0.91	0.00	0.61	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	2.59	3.62	0.52	1.55	2.07	0.00	0.52	0.00	1.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	4.65	1.33	0.66	1.99	0.00	0.00	1.33	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	2.57	3.59	0.26	1.03	1.80	0.00	0.00	0.26	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	7.93	9.20	1.79	3.58	1.79	1.02	0.51	0.77	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	6.06	6.06	0.00	3.79	0.76	0.00	3.79	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	7.06	10.08	0.34	3.02	2.69	1.34	0.34	0.34	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	3.38	1.45	0.24	3.38	1.93	0.24	0.24	0.00	0.24
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	6.24	2.23	0.00	2.67	0.45	0.00	1.34	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	3.90	1.46	0.98	2.44	1.95	0.00	1.46	0.00	0.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	2.44	1.53	0.61	0.61	0.61	0.00	0.00	0.31	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	9.76	3.25	0.00	0.00	0.00	0.00	0.00	0.00	3.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	3.31	0.66	0.33	0.99	0.33	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	5.47	1.64	2.19	3.28	2.74	0.00	0.55	0.00	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	6.88	6.15	0.36	3.26	0.72	0.00	0.00	0.00	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	1.78	2.85	0.36	1.78	0.36	0.00	0.36	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	4.77	7.16	0.00	4.77	1.19	0.00	1.19	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	9.62	14.08	1.76	3.93	2.03	0.41	1.63	0.14	0.41
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	3.23	10.24	0.54	2.69	1.08	0.54	1.35	0.00	0.27
immature langerhans cells, donor1	11904-125F5	0.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
immature langerhans cells, donor2	11905-125F6	2.38	4.75	0.00	0.00	0.79	0.00	0.00	0.00	0.00
insula, adult, pool1	10039-101F3	42.77	22.81	10.13	3.69	5.39	4.26	1.23	0.76	0.28
keratoacanthoma cell line:HKA-1	10791-110H8	3.58	8.45	0.65	0.65	0.00	0.98	0.98	0.00	0.00
kidney, adult, pool1	10017-101C8	16.92	25.93	4.91	3.30	1.90	1.60	0.20	0.40	0.30
kidney, fetal, pool1	10045-101F9	27.09	30.77	6.37	4.95	3.96	2.05	0.42	0.35	0.50
large cell lung carcinoma cell line:IA-LM	10509-107D5	27.98	8.10	3.27	5.25	4.83	1.14	1.85	0.14	1.14
large cell lung carcinoma cell line:NCI-H460	10839-111E2	8.43	12.17	1.80	2.35	0.83	0.55	2.07	0.00	0.69
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	12.29	7.34	4.95	1.65	1.28	0.55	0.18	0.00	0.00
left atrium, adult, donor1	10079-102A7	7.08	10.90	2.18	2.72	0.00	1.63	0.54	0.54	0.00
left ventricle, adult, donor1	10078-102A6	6.57	9.61	3.03	4.55	1.01	1.01	0.00	1.52	0.51
leiomyoblastoma cell line:G-402	10721-110A1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
leiomyoma cell line:10964C	10569-108B2	7.90	6.11	1.44	3.23	1.44	1.08	0.36	0.72	0.00
leiomyoma cell line:15242A	10570-108B3	29.35	14.67	3.80	3.26	2.72	3.80	1.63	0.00	0.00
leiomyoma cell line:15425	10571-108B4	5.10	4.13	0.97	1.94	1.46	0.73	0.73	0.49	0.24
leiomyosarcoma cell line:Hs 5.T	10722-110A2	6.35	19.05	6.35	6.35	0.00	6.35	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	13.59	17.77	2.09	1.05	0.00	0.00	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	8.38	4.96	2.24	1.18	0.71	0.71	1.18	0.12	1.18
liposarcoma cell line:KMLS-1	10782-110G8	9.84	7.50	2.34	2.81	2.81	1.25	0.78	0.47	0.62
liposarcoma cell line:SW 872	10726-110A6	383.92	213.95	113.68	24.98	24.00	66.77	3.66	31.31	2.56
liver, adult, pool1	10018-101C9	10.05	20.74	3.08	2.43	1.30	2.27	2.27	0.16	0.16
liver, fetal, pool1	10086-102B5	6.58	9.41	2.82	2.82	0.94	1.88	0.00	0.00	0.94
locus coeruleus - adult, donor10196	10182-103D2	25.23	18.52	7.58	3.79	3.65	2.48	0.87	1.75	0.00
locus coeruleus, adult, donor10252	10165-103B3	23.81	26.94	9.04	4.43	3.69	2.21	0.92	1.48	0.18
locus coeruleus, adult, donor10258	10375-105G6	12.41	16.93	3.95	4.51	1.13	2.82	0.28	0.28	0.28
locus coeruleus, newborn, donor10223	10362-105F2	15.14	10.09	2.10	5.89	3.36	1.26	0.42	0.42	0.84
lung adenocarcinoma cell line:A549	10499-107C4	9.13	2.63	2.49	0.42	0.55	0.42	1.66	0.28	0.28
lung adenocarcinoma cell line:PC-14	10408-106B3	10.34	7.58	2.76	0.69	0.00	2.07	0.00	0.00	0.69
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	30.84	21.75	6.85	5.93	3.03	3.30	0.13	1.58	0.00
lung, adult, pool1	10019-101D1	17.36	26.46	5.08	4.25	1.06	2.48	0.71	0.24	0.00
lung, fetal, donor1	10068-101I5	49.38	33.68	6.28	7.99	2.28	5.42	1.43	1.43	0.00
lung, right lower lobe, adult, donor1	10075-102A3	4.12	4.58	2.75	0.00	0.00	0.00	0.00	0.46	0.00
lymph node, adult, donor1	10077-102A5	4.26	3.79	0.00	0.47	0.00	0.95	0.00	0.00	0.47
lymphangiectasia cell line:DS-1	10727-110A7	2.19	0.66	0.88	0.88	0.66	0.44	0.00	0.44	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	25.36	4.23	4.98	0.60	3.62	0.30	5.28	0.15	2.57
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	0.85	0.85	0.00	0.85	0.00	0.00	0.85	0.00	0.00
mature adipocyte, donor1	12231-129F8	55.94	76.37	11.99	17.76	3.11	10.21	0.89	3.55	0.00
mature adipocyte, donor2	12232-129F9	56.86	71.18	23.04	13.70	5.40	10.79	1.25	2.91	0.42
mature adipocyte, donor3	12233-129G1	60.93	83.92	27.97	12.56	3.79	9.48	2.84	2.84	0.00
mature adipocyte, donor4	12234-129G2	45.80	45.01	15.27	7.90	3.42	5.26	1.32	3.16	0.79
maxillary sinus tumor cell line:HSQ-89	10414-106B9	31.69	33.12	5.00	5.96	5.00	1.67	6.19	2.38	0.71
medial frontal gyrus - adult, donor10196	10170-103B8	18.05	13.54	6.77	0.00	4.51	4.51	0.00	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	39.72	34.57	22.44	8.46	6.62	5.89	1.47	1.84	0.55
medial frontal gyrus, adult, donor10258	10368-105F8	26.37	6.99	8.26	4.13	1.27	4.77	0.32	0.95	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	7.68	4.26	1.28	2.13	1.71	2.13	2.13	0.43	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	29.87	18.23	5.23	4.39	2.70	2.87	1.18	0.68	0.51
medial temporal gyrus, adult, donor10252	10156-103A3	42.02	39.69	15.92	7.64	5.09	6.15	0.85	2.12	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	38.53	15.41	0.00	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	43.06	14.35	14.35	0.00	14.35	0.00	0.00	14.35	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	7.54	5.38	1.08	1.44	0.36	0.36	1.08	1.08	0.72
medulla oblongata - adult, donor10196	10174-103C3	23.36	5.19	6.49	5.84	1.30	3.89	0.65	1.95	0.00
medulla oblongata, adult, donor10252	10155-103A2	28.48	27.86	8.36	5.57	5.11	4.64	0.77	1.70	0.46
medulla oblongata, adult, pool1	10038-101F2	38.12	27.35	9.63	6.94	4.82	6.04	1.22	1.39	0.57
medulla oblongata, newborn, donor10223	10361-105F1	34.37	35.07	5.55	8.33	4.17	4.86	2.43	1.04	1.04
medulloblastoma cell line:D283 Med	10838-111E1	20.15	11.07	1.11	2.44	2.66	0.00	1.55	0.00	1.11
medulloblastoma cell line:ONS-76	10759-110E3	14.67	13.45	3.91	2.20	2.08	1.96	1.35	0.49	0.61
melanoma cell line:COLO 679	10514-107E1	80.93	20.99	21.42	7.47	10.35	11.93	4.17	5.75	2.73
melanoma cell line:G-361	10465-106H6	10.32	5.43	1.90	2.99	2.17	1.09	1.63	0.27	0.27
meningioma cell line:HKBMM	10691-109F7	6.51	4.16	0.54	0.54	1.09	0.18	0.36	0.00	0.18
merkel cell carcinoma cell line:MKL-1	10843-111E6	26.43	26.43	1.76	1.76	2.64	3.52	3.52	0.88	1.76
merkel cell carcinoma cell line:MS-1	10844-111E7	12.44	14.00	1.81	0.26	2.33	2.33	3.11	0.26	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	9.82	17.03	3.07	4.14	1.69	1.23	0.77	0.61	0.31
mesenchymal precursor cell - adipose, donor2	11748-123G2	7.27	17.45	2.00	2.00	1.64	0.73	0.55	0.55	0.18
mesenchymal precursor cell - adipose, donor3	11749-123G3	6.21	8.70	2.48	1.66	1.66	0.41	0.41	0.00	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	13.06	13.63	3.65	3.09	1.83	2.25	0.28	0.28	0.28
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	11.36	9.63	3.08	3.08	2.89	1.16	0.00	0.19	0.58
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	14.58	7.63	1.39	1.39	0.00	0.69	0.69	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	10.13	8.58	4.98	3.60	1.89	3.26	0.51	1.03	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	4.95	7.02	1.73	1.61	1.84	0.69	0.58	0.58	0.23
mesenchymal precursor cell - cardiac, donor3	11754-123G8	14.32	24.01	3.45	4.24	2.79	2.79	1.46	0.93	0.27
mesenchymal precursor cell - cardiac, donor4	11755-123G9	13.50	13.77	5.67	3.38	2.30	2.70	0.95	0.54	0.95
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	23.33	19.92	8.11	2.85	4.13	4.41	2.42	1.42	0.71
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	21.41	16.47	4.94	6.26	2.63	4.61	3.29	1.65	0.66
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	15.08	21.17	5.67	3.04	3.18	1.38	1.38	0.55	0.42
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	9.43	12.22	1.75	2.09	1.05	0.35	0.35	0.35	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	10.82	11.23	3.47	3.06	3.27	0.82	1.02	0.00	0.61
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	19.77	15.82	2.88	3.24	1.08	3.24	0.00	0.00	0.72
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	3.21	4.45	0.62	2.17	0.83	0.31	0.21	0.10	0.10
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	6.61	7.75	1.14	3.19	0.91	1.14	0.46	0.00	0.46
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	15.94	17.20	5.03	5.45	4.62	2.10	0.42	0.00	1.68
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	19.58	20.92	7.92	5.68	4.33	2.69	1.34	0.60	0.90
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	9.19	17.33	3.68	2.98	2.28	1.49	0.70	0.18	0.79
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	25.03	22.46	4.42	7.36	2.21	1.47	1.10	0.37	0.74
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	17.17	14.02	4.58	4.86	2.29	2.29	1.43	0.29	1.14
mesenchymal stem cell line:Hu5/E18	10568-108B1	16.00	10.53	7.16	5.05	0.84	8.42	1.26	7.16	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	15.98	14.16	1.83	3.20	1.83	2.28	0.46	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	11.77	16.11	1.79	3.33	2.05	2.05	0.26	0.26	0.51
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	12.83	15.97	3.40	3.66	1.57	1.05	0.26	0.00	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	15.10	11.71	2.77	2.77	0.31	2.16	0.00	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	9.88	17.42	3.06	4.47	2.12	1.88	0.94	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	14.55	12.86	3.72	3.72	1.02	0.68	0.00	0.68	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	15.72	14.93	3.14	4.72	2.36	1.96	0.39	0.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	11.58	15.76	1.39	1.85	1.85	0.93	0.00	1.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	48.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	14.42	22.50	4.61	6.06	3.75	2.02	1.15	0.58	0.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	15.39	14.50	3.35	4.46	1.78	1.56	0.67	0.45	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	12.02	14.66	2.88	2.64	2.88	1.44	0.72	1.20	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	16.13	13.20	5.87	1.47	2.20	3.67	1.47	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	12.08	13.09	2.01	4.70	1.34	0.67	0.67	1.01	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	12.69	12.69	3.68	4.91	1.23	1.23	0.41	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	13.75	13.75	4.73	3.44	2.58	0.86	0.00	0.43	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	13.67	8.20	2.73	5.47	2.73	8.20	2.73	2.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	15.49	25.82	0.00	5.16	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	13.32	14.94	3.25	1.62	1.95	0.65	0.32	0.65	0.32
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	14.55	13.09	2.91	4.36	0.00	1.45	1.45	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	14.39	12.79	1.07	4.80	2.13	0.00	0.00	0.53	1.07
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	11.45	10.63	2.45	1.64	2.45	0.82	0.82	0.82	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	10.11	16.71	2.72	6.22	1.94	0.78	0.78	0.78	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	20.99	12.59	2.10	0.00	0.00	2.10	4.20	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	3.97	19.87	2.98	8.94	1.99	1.99	0.99	0.00	1.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	4.77	38.14	0.00	0.00	0.00	0.00	4.77	0.00	4.77
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	13.05	20.16	2.96	6.52	1.78	2.37	0.59	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	19.50	10.97	3.66	8.53	1.22	1.22	1.22	1.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	17.73	17.10	1.27	9.50	1.90	1.27	2.53	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	16.21	30.70	3.79	7.24	3.45	2.41	0.34	0.69	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	8.60	40.83	4.30	6.45	0.00	2.15	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	3.99	23.95	3.99	3.99	0.00	7.98	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	27.55	13.78	0.00	13.78	3.44	6.89	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	12.22	26.08	3.67	7.33	1.22	2.85	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	16.68	25.42	3.18	7.94	0.79	3.18	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	18.28	21.81	6.48	3.54	0.59	2.95	0.00	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	19.01	17.77	5.61	5.61	1.87	2.81	0.62	0.31	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	14.70	21.39	4.01	4.01	2.67	4.01	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	16.56	17.74	5.91	5.91	0.00	3.55	1.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	15.41	17.98	5.14	5.14	0.00	10.27	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	22.03	11.70	6.88	4.13	2.75	3.44	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	23.26	18.80	7.42	5.44	1.48	6.93	1.98	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	16.82	22.43	4.49	6.73	2.24	3.36	1.12	1.12	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	15.90	19.72	5.09	6.36	2.54	7.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	12.90	20.15	5.24	5.64	2.01	2.82	0.81	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	10.90	19.63	4.36	2.18	0.00	6.54	2.18	2.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	12.67	11.40	5.07	8.87	0.00	1.27	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	21.85	29.74	7.89	7.28	0.61	4.25	0.00	1.21	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	31.63	49.71	13.56	9.04	0.00	18.08	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	23.06	26.36	7.41	5.77	0.00	3.29	0.00	0.82	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	29.76	24.01	5.95	6.35	2.78	4.96	0.20	0.99	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	22.71	18.82	8.11	6.17	0.97	3.57	0.65	0.97	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	27.50	27.50	10.19	7.13	1.02	9.17	0.00	0.00	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	4.64	6.19	2.32	0.00	0.00	2.32	0.77	0.77	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	14.88	4.96	3.31	0.71	3.31	0.94	0.71	0.47	0.71
mesothelioma cell line:ACC-MESO-4	10494-107B8	19.23	25.48	4.87	1.62	3.24	0.93	0.46	0.00	0.70
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	17.09	17.09	4.27	0.00	0.00	0.00	4.27	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	8.73	8.63	2.47	2.36	1.75	0.72	0.62	0.21	0.31
mesothelioma cell line:Mero-25	10850-111F4	8.85	12.26	0.68	2.72	2.04	0.68	0.91	0.00	0.45
mesothelioma cell line:Mero-41	10851-111F5	28.60	89.23	4.89	11.98	2.20	3.91	0.49	0.24	0.98
mesothelioma cell line:Mero-48a	10852-111F6	111.82	72.85	20.15	16.16	9.30	16.16	0.66	4.87	0.66
mesothelioma cell line:Mero-82	10853-111F7	47.04	42.31	11.04	6.04	4.47	6.04	2.10	0.79	1.05
mesothelioma cell line:Mero-83	10854-111F8	11.75	20.77	2.21	2.72	1.87	1.19	0.85	0.00	0.17
mesothelioma cell line:Mero-84	10855-111F9	0.51	1.26	0.00	0.25	0.25	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-95	10856-111G1	15.53	40.99	3.31	6.83	1.86	3.52	1.45	0.00	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	19.38	18.55	1.99	6.29	3.15	1.99	0.99	0.83	0.83
mesothelioma cell line:NCI-H226	10846-111E9	6.52	10.32	0.72	2.53	0.90	1.63	0.18	0.18	0.00
mesothelioma cell line:NCI-H2452	10848-111F2	26.48	28.70	4.27	5.30	2.90	4.61	1.54	1.20	0.68
mesothelioma cell line:NCI-H28	10845-111E8	9.42	5.85	1.53	2.04	1.53	1.78	0.51	0.00	0.25
mesothelioma cell line:No36	10857-111G2	40.78	39.47	7.50	9.13	4.89	4.89	0.33	1.30	0.00
mesothelioma cell line:ONE58	10858-111G3	40.91	33.60	4.88	5.69	3.25	8.40	0.54	0.54	1.35
migratory langerhans cells, donor1	11901-125F2	0.38	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
migratory langerhans cells, donor2	11902-125F3	0.00	0.12	0.00	0.12	0.12	0.00	0.00	0.00	0.00
migratory langerhans cells, donor3	11903-125F4	1.26	0.18	0.00	0.00	0.18	0.18	0.00	0.00	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	32.32	29.38	9.79	4.24	5.22	3.26	0.33	1.31	0.33
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	9.54	21.19	3.81	2.97	1.27	0.85	0.21	0.21	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	12.44	6.22	5.30	0.92	1.38	1.38	1.15	0.46	0.69
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	6.84	2.59	1.29	2.03	1.29	0.55	4.25	0.18	1.48
myeloma cell line:PCM6	10474-106I6	0.99	0.40	0.20	0.20	0.20	0.20	0.00	0.00	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	25.36	14.20	3.04	0.51	4.06	2.03	0.51	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	7.65	6.67	2.55	1.77	1.37	2.16	0.98	0.20	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	0.56	0.45	0.11	0.22	0.00	0.11	0.00	0.00	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	0.15	0.22	0.00	0.15	0.00	0.00	0.00	0.00	0.00
nasal epithelial cells, donor2	12227-129F4	2.76	2.21	1.66	1.66	1.10	0.00	0.00	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	51.07	7.36	11.73	0.69	5.52	3.45	3.45	0.92	3.45
neuroblastoma cell line:NB-1	10539-107G8	38.54	15.15	8.23	1.68	8.04	4.68	7.48	0.37	6.92
neuroblastoma cell line:NBsusSR	10607-108F4	8.22	8.86	1.05	2.11	1.48	0.00	0.21	0.00	0.00
neuroblastoma cell line:NH-12	10555-107I6	47.15	33.54	8.57	2.42	10.44	1.86	4.85	0.19	4.47
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	13.76	33.92	0.95	1.42	4.27	1.19	1.19	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	8.24	10.77	1.90	0.32	2.38	0.16	0.79	0.00	0.32
neuroectodermal tumor cell line:TASK1	10774-110F9	4.23	3.82	0.81	0.60	1.61	0.20	1.61	0.00	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	23.52	24.79	0.64	2.54	4.45	0.64	0.00	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	14.91	11.71	3.99	2.40	2.93	2.13	0.80	0.27	0.27
neutrophil PMN, donor1	12133-128D9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	56.32	2.20	8.12	0.68	7.78	2.37	8.29	1.69	2.03
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	4.80	13.61	0.00	0.00	0.80	0.80	0.80	0.00	1.60
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	45.53	26.29	14.75	6.09	7.37	7.05	0.32	0.96	0.96
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	27.06	34.16	4.73	3.42	3.42	3.68	1.31	1.84	0.53
nucleus accumbens, adult, pool1	10037-101F1	53.15	24.84	10.87	5.34	6.00	6.66	0.84	1.78	0.28
occipital cortex - adult, donor10196	10172-103C1	28.85	14.42	8.24	6.18	6.18	4.12	0.00	2.06	0.00
occipital cortex, adult, donor10252	10163-103B1	46.16	45.62	19.59	6.71	11.00	5.90	1.07	1.07	0.81
occipital cortex, newborn, donor10223	10355-105E4	5.10	7.28	1.09	2.18	2.18	1.46	0.73	0.00	0.00
occipital lobe, adult, donor1	10076-102A4	28.08	16.53	9.18	1.57	1.57	3.94	0.79	1.31	0.00
occipital lobe, fetal, donor1	10073-102A1	17.59	10.73	3.86	3.43	5.15	2.57	0.43	0.00	1.29
occipital pole, adult, pool1	10036-101E9	38.00	18.69	10.80	3.07	3.47	5.76	0.95	1.34	0.47
olfactory region, adult	10195-103E6	49.86	25.41	11.27	5.73	5.54	5.35	0.19	1.72	0.00
optic nerve, donor1	10277-104E7	32.02	54.03	0.00	4.00	2.00	4.00	2.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	5.81	23.69	1.48	3.53	0.34	1.03	1.03	0.23	0.00
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	15.94	11.68	3.16	3.30	2.47	0.69	0.55	0.27	0.14
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	6.10	5.08	1.52	1.19	1.19	0.51	1.86	0.00	0.51
oral squamous cell carcinoma cell line:SAS	10544-107H4	36.39	40.43	11.78	8.78	5.20	5.08	1.73	1.16	0.92
osteoclastoma cell line:Hs 706.T	10704-109H2	10.29	10.58	2.35	1.18	0.59	0.29	0.29	0.59	0.59
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	14.02	13.08	1.87	0.00	4.67	0.93	1.87	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	19.51	17.60	4.88	5.09	2.54	4.24	1.27	3.82	0.21
ovary, adult, pool1	10020-101D2	35.55	34.15	5.68	9.70	4.63	1.31	0.52	0.26	0.44
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	11.37	3.67	1.10	1.28	0.92	0.55	0.73	0.18	0.73
pancreas, adult, donor1	10049-101G4	19.75	47.97	11.29	11.29	0.00	3.76	0.94	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	18.57	21.98	4.94	3.07	1.70	2.21	1.36	0.17	1.70
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	27.98	25.17	5.30	6.13	2.81	1.82	0.50	0.33	0.50
paracentral gyrus, adult, pool1	10035-101E8	42.83	21.87	11.90	3.84	4.76	5.03	0.92	1.56	0.27
parietal cortex, adult, donor10258	10373-105G4	30.09	8.07	1.47	6.61	4.40	5.87	0.00	0.73	0.00
parietal lobe - adult, donor10196	10171-103B9	31.98	14.11	4.70	4.70	1.88	2.82	0.00	0.94	0.00
parietal lobe, adult, donor10252	10157-103A4	37.62	31.92	14.25	8.27	3.42	4.56	0.29	2.57	0.00
parietal lobe, adult, pool1	10034-101E7	40.98	23.70	11.10	4.32	5.11	5.02	0.88	1.76	0.35
parietal lobe, fetal, donor1	10072-101I9	16.49	17.46	5.82	0.97	0.00	0.00	1.94	0.00	1.94
parietal lobe, newborn, donor10223	10356-105E5	10.09	5.23	0.75	1.50	1.12	1.50	1.12	0.37	0.00
parotid gland, adult	10199-103F1	11.10	53.03	3.70	2.47	1.23	0.62	0.62	0.62	0.00
penis, adult	10200-103F2	10.21	12.35	3.22	2.15	1.07	1.07	0.54	0.00	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	5.39	4.83	0.19	0.19	0.74	0.19	0.19	0.00	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	30.30	33.22	8.01	6.56	3.93	4.52	3.21	0.29	1.60
pineal gland - adult, donor10196	10179-103C8	14.84	5.16	7.74	3.87	2.58	1.29	0.00	0.65	0.00
pineal gland, adult, donor10252	10160-103A7	36.72	4.15	9.48	4.15	7.70	4.15	1.18	0.59	0.00
pineal gland, adult, donor10258	10377-105G8	20.69	3.76	1.88	5.02	1.88	3.14	1.25	0.63	0.63
pituitary gland - adult, donor10196	10180-103C9	23.27	10.12	3.04	7.08	2.02	0.00	1.01	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	42.22	30.75	17.20	8.34	5.21	3.65	0.00	0.52	0.00
pituitary gland, adult, donor10258	10378-105G9	15.32	12.77	5.96	0.85	0.00	0.85	0.00	0.00	0.00
placenta, adult, pool1	10021-101D3	180.60	107.61	36.87	21.07	12.79	10.75	1.83	2.58	0.86
plasma cell leukemia cell line:ARH-77	10840-111E3	23.84	4.50	3.05	1.59	4.50	1.59	0.93	0.53	0.66
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	13.07	24.90	4.05	2.80	0.78	3.11	0.93	0.62	0.31
pons, adult, pool1	10033-101E6	19.45	17.99	6.54	2.75	3.61	2.32	1.03	0.26	0.17
postcentral gyrus, adult, pool1	10032-101E5	36.00	20.22	9.33	5.14	5.06	4.45	1.05	1.22	0.17
promyelocytes/myelocytes PMC, donor1	12132-128D8	35.55	0.00	6.27	2.09	18.82	0.00	2.09	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	0.00	0.00	0.00	0.00	5.51	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	11.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	12.96	9.03	2.18	3.50	2.77	1.60	1.02	0.73	0.15
prostate cancer cell line:PC-3	10439-106E7	4.72	4.54	0.54	0.54	0.36	0.18	0.18	0.00	0.36
prostate, adult, pool1	10022-101D4	20.41	22.85	5.44	3.45	2.63	2.45	0.54	0.36	0.09
putamen, adult, donor10196	10176-103C5	46.03	31.16	16.76	4.72	6.37	4.72	1.18	1.18	0.00
putamen, adult, donor10252	10152-102I8	41.18	25.49	7.84	3.92	3.92	5.88	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	53.55	2.19	4.37	2.19	4.37	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	39.62	20.78	7.25	3.87	5.32	4.11	0.48	1.93	0.00
putamen, newborn, donor10223	10365-105F5	14.99	9.75	4.50	5.25	0.75	1.50	1.50	0.00	0.75
rectal cancer cell line:TT1TKB	10469-106I1	17.46	17.46	2.91	1.45	2.62	2.62	1.16	0.29	0.58
rectum, fetal, donor1	10067-101I4	18.08	25.04	4.17	1.39	5.56	1.39	1.39	0.00	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	7.84	10.81	1.48	1.48	1.70	0.64	0.64	0.00	0.42
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	19.88	5.38	2.07	2.49	1.66	0.83	0.41	0.41	0.83
retina, adult, pool1	10030-101E3	52.28	45.13	11.63	10.74	7.65	4.37	0.50	0.80	0.30
retinoblastoma cell line:Y79	10475-106I7	15.85	10.91	2.86	1.30	2.86	0.26	1.56	0.00	1.82
rhabdomyosarcoma cell line:KYM-1	10787-110H4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	26.43	12.94	9.00	3.37	3.09	5.91	1.12	1.12	0.28
sacrococcigeal teratoma cell line:HTST	10695-109G2	71.24	43.96	13.64	4.55	3.03	9.85	1.52	0.00	0.00
salivary acinar cells, donor1	11771-123I7	5.50	11.01	1.46	1.94	0.81	0.49	0.16	0.16	0.16
salivary acinar cells, donor2	11772-123I8	4.27	7.30	1.24	0.83	0.83	0.14	0.14	0.00	0.00
salivary acinar cells, donor3	11773-123I9	6.62	9.93	2.65	0.00	0.00	0.66	0.00	0.00	0.00
salivary gland, adult, pool1	10093-102C3	37.18	52.62	7.44	1.72	3.43	2.86	1.72	0.57	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	14.75	16.78	1.85	5.65	3.63	1.43	2.02	0.42	0.84
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	12.81	11.40	2.35	6.58	3.53	0.82	2.12	0.24	2.35
seminal vesicle, adult	10201-103F3	17.99	17.46	7.94	1.06	2.12	2.65	0.00	1.59	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	12.15	8.75	3.64	2.43	1.46	1.70	0.97	0.73	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	4.28	7.80	1.76	0.75	2.77	0.50	0.25	0.50	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	9.03	7.02	0.00	0.00	1.00	0.00	3.01	2.01	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	16.25	24.71	2.55	3.36	2.42	1.48	0.67	0.27	0.13
signet ring carcinoma cell line:Kato III	10436-106E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	0.00	0.00	0.13	0.00	0.00	0.00	0.00	0.00	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	9.22	14.90	2.84	0.00	2.84	0.71	1.42	1.42	0.71
skeletal muscle, adult, pool1	10023-101D5	14.75	23.75	4.80	1.68	1.32	3.60	0.84	3.36	0.60
skeletal muscle, fetal, donor1	10066-101I3	9.05	12.06	4.02	1.01	2.01	1.01	1.01	3.02	1.01
skin, adult, donor1	10074-102A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	20.83	18.31	6.31	5.05	2.52	5.05	1.89	0.00	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	12.01	23.35	3.00	1.33	1.00	0.67	2.33	0.33	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	11.66	11.03	4.41	3.15	1.26	1.89	1.89	0.95	1.26
small cell lung carcinoma cell line:DMS 144	10841-111E4	10.41	2.89	0.96	0.77	4.43	0.58	0.58	0.00	0.58
small cell lung carcinoma cell line:LK-2	10541-107H1	6.26	31.32	0.99	0.33	2.64	0.82	2.97	0.16	0.66
small cell lung carcinoma cell line:NCI-H82	10842-111E5	15.76	6.27	2.73	0.32	2.09	0.64	0.64	0.00	1.29
small cell lung carcinoma cell line:WA-hT	10562-108A4	10.68	20.27	1.96	2.40	4.36	0.87	1.09	0.44	1.09
small intestine, adult, pool1	10024-101D6	10.99	18.51	2.99	1.31	1.07	2.27	1.07	0.84	0.24
small intestine, fetal, donor1	10064-101I1	10.81	15.72	3.19	2.95	1.72	0.98	0.98	0.25	0.74
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	6.67	19.49	0.51	2.56	0.00	0.51	2.05	0.00	0.00
smooth muscle, adult, pool1	10048-101G3	10.60	10.86	4.14	3.62	0.78	0.26	0.26	0.52	0.26
somatostatinoma cell line:QGP-1	10781-110G7	12.87	10.18	2.95	1.34	0.54	0.80	0.27	0.00	0.27
spinal cord - adult, donor10196	10181-103D1	13.31	16.06	5.96	4.13	3.90	4.36	0.92	1.84	0.46
spinal cord, adult, donor10252	10159-103A6	31.54	24.44	10.25	5.13	5.13	2.76	0.79	1.58	0.39
spinal cord, adult, donor10258	10369-105F9	30.44	10.38	6.92	8.30	2.77	2.08	4.15	0.69	0.69
spinal cord, fetal, donor1	10056-101H2	28.66	21.34	11.59	7.93	1.83	6.71	1.83	1.83	0.00
spinal cord, newborn, donor10223	10359-105E8	27.09	20.21	3.21	15.61	2.30	3.67	3.21	0.92	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	6.87	9.86	2.39	2.24	2.09	1.64	1.19	0.30	0.75
spleen, adult, pool1	10025-101D7	13.00	7.71	3.19	2.09	1.76	1.10	0.88	0.55	1.21
spleen, fetal, pool1	10044-101F8	21.69	11.04	5.16	2.86	2.62	2.54	0.79	0.48	0.64
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	10.25	14.24	2.85	2.66	1.33	0.38	1.14	0.00	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	16.77	14.68	5.59	8.39	4.54	2.10	3.15	1.05	0.70
squamous cell carcinoma cell line:T3M-5	10616-108G4	4.69	1.95	0.78	0.78	0.39	0.39	0.00	0.00	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	9.00	19.92	2.48	4.84	0.90	1.01	1.46	0.79	0.68
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	0.85	0.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	24.12	18.62	3.38	5.50	0.85	2.96	1.27	0.85	0.42
stomach, fetal, donor1	10062-101H8	16.02	22.43	10.68	1.07	0.00	7.48	0.00	3.20	0.00
submaxillary gland, adult	10202-103F4	14.81	52.98	1.14	5.13	1.14	1.14	2.28	0.57	0.00
substantia nigra - adult, donor10196	10178-103C7	54.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	29.70	34.06	14.33	6.23	5.19	5.82	1.25	0.83	0.21
substantia nigra, adult, donor10258	10371-105G2	36.21	10.86	6.21	3.10	1.55	3.10	1.55	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	33.92	20.49	4.24	4.95	2.83	4.95	3.53	0.00	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	12.15	7.34	2.06	2.06	3.44	0.92	3.67	0.00	1.38
temporal lobe, adult, pool1	10031-101E4	32.64	20.68	8.90	2.80	5.26	4.15	0.42	1.02	0.08
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	8.55	13.53	4.99	0.71	4.27	0.71	0.71	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	18.02	22.86	3.08	3.52	3.08	1.32	0.44	0.44	0.44
tenocyte, donor1	11763-123H8	13.61	20.60	3.49	5.93	1.75	0.35	0.35	0.35	0.35
tenocyte, donor2	11765-123I1	16.40	11.06	2.29	3.43	2.67	0.76	0.00	0.76	0.00
tenocyte, donor3	11768-123I4	11.12	15.20	2.59	3.34	3.34	1.11	0.37	0.00	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	2.72	0.51	0.00	0.34	0.68	0.17	0.00	0.00	0.00
teratocarcinoma cell line:NCR-G1	10798-110I6	29.60	13.57	9.25	9.25	5.55	4.93	0.62	0.31	0.62
teratocarcinoma cell line:PA-1	10807-111A6	2.94	1.08	0.77	0.93	0.62	0.15	1.08	0.15	0.77
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	0.63	0.63	0.00	0.13	0.25	0.00	0.38	0.13	0.00
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	0.00	0.00	0.00	0.76	0.00	0.76	0.38	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	0.55	0.22	0.22	0.44	0.11	0.22	0.11	0.11	0.00
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	0.00	0.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00
testis, adult, pool1	10026-101D8	31.57	40.37	9.13	9.77	2.68	3.22	0.64	0.54	0.64
testis, adult, pool2	10096-102C6	32.03	33.83	3.61	9.92	3.61	2.26	0.45	0.45	0.00
thalamus - adult, donor10196	10168-103B6	32.02	17.66	7.73	13.25	0.00	4.42	4.42	2.21	0.00
thalamus, adult, donor10252	10154-103A1	48.29	48.29	16.41	7.97	6.10	6.72	0.63	1.56	0.16
thalamus, adult, donor10258, tech_rep1	10370-105G1	106.23	9.24	3.08	6.16	6.16	3.08	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	15.48	15.81	4.45	3.13	2.47	2.80	0.33	1.32	0.00
thalamus, newborn, donor10223	10366-105F6	9.21	6.90	1.73	2.30	1.15	1.15	0.58	0.00	0.00
throat, adult	10209-103G2	15.48	20.72	2.25	3.50	2.00	2.00	0.00	0.75	0.00
throat, fetal, donor1	10061-101H7	18.59	21.02	3.35	4.27	1.22	1.83	1.22	0.30	1.52
thymic carcinoma cell line:Ty-82	10803-111A2	2.58	9.14	0.20	0.79	0.40	0.00	0.99	0.20	0.00
thymus, adult, pool1	10027-101D9	6.66	1.89	0.70	0.89	1.79	0.40	0.20	0.00	0.10
thymus, fetal, pool1	10043-101F7	19.22	10.70	2.81	3.74	2.70	0.73	0.52	0.21	0.00
thyroid carcinoma cell line:KHM-5M	10776-110G2	21.01	25.40	5.58	6.52	3.06	2.79	1.99	1.86	1.86
thyroid carcinoma cell line:TCO-1	10783-110G9	53.08	88.70	17.46	13.13	6.43	7.40	4.19	3.07	3.21
thyroid, adult, pool1	10028-101E1	20.44	15.68	5.04	2.80	2.24	2.05	0.47	0.47	0.19
thyroid, fetal, donor1	10060-101H6	8.96	7.65	2.37	1.85	1.32	1.85	0.79	0.53	0.26
tongue epidermis (fungiform papillae), donor1	10288-104F9	21.56	27.72	6.16	6.16	0.00	6.16	3.08	0.00	0.00
tongue, adult	10203-103F5	5.35	8.37	2.09	2.09	0.00	1.40	0.47	0.23	0.00
tongue, fetal, donor1	10059-101H5	16.95	19.31	3.55	5.12	1.18	0.79	0.79	1.18	0.79
tonsil, adult, pool1	10047-101G2	3.61	5.31	1.20	0.30	0.70	0.50	0.50	0.00	0.20
trachea, adult, pool1	10029-101E2	15.54	16.52	3.93	3.03	1.31	1.72	0.25	0.25	0.25
trachea, fetal, donor1	10058-101H4	21.54	25.77	5.77	7.31	3.46	1.54	1.54	0.00	0.38
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	48.89	28.70	9.57	6.73	4.61	4.61	1.42	2.48	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	25.13	40.83	3.55	4.86	3.14	4.05	2.84	0.61	1.22
transitional-cell carcinoma cell line:JMSU1	10492-107B6	13.48	13.48	2.66	4.23	2.35	1.25	1.57	0.00	1.25
tridermal teratoma cell line:HGRT	10694-109G1	30.44	38.05	3.81	0.00	1.90	0.00	1.90	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	6.18	3.56	1.27	0.51	1.27	0.08	0.42	0.00	0.25
umbilical cord, fetal, donor1	10057-101H3	14.61	10.43	6.26	4.17	4.17	2.09	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	15.36	10.07	1.88	2.56	3.07	1.37	0.68	0.34	0.34
uterus, fetal, donor1	10055-101H1	13.82	12.29	3.58	3.58	3.07	1.02	0.51	0.00	0.51
vagina, adult	10204-103F6	18.74	27.14	2.58	2.58	2.58	1.29	0.65	0.00	0.00
vein, adult	10191-103E2	15.34	18.41	2.41	2.41	1.32	1.53	1.10	0.66	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	14.95	2.14	1.07	0.53	1.87	0.53	0.53	0.00	0.53